DC.ID,SMILES_stand,InChI,SMILES,DC.NAME,NCATS.SYNONYMS,NCGC.ID,AlphaLISA.ACTIVITY,AlphaLISA.SIGNIFICANCE,logPow {predicted by ochem.eu/model/535 in Log unit},Aqueous Solubility {predicted by ochem.eu/model/536 in log(mol/L)},Label
1094.0,CCC1(O)CCC2C3CCC4=CCCCC4C3CCC21C,,CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C,ethylestrenol,Ethylestrenol,,MODERATE,MODERATE,5.2,-5.53,1
1679.0,CC12CC3CC(C)(C1)CC(N)(C3)C2,,CC12CC3CC(C)(C1)CC(N)(C3)C2,memantine,Memantine hydrochloride,NCGC00015705-13,LOW,INACTIVE,3.31,-3.6,0
,CC=CC1C(C(=O)OCc2c(F)c(F)c(COC)c(F)c2F)C1(C)C,,CC=CC1C(C(=O)OCc2c(F)c(F)c(COC)c(F)c2F)C1(C)C,,,NCGC00319021-01,MODERATE,LOW,4.21,-3.94,1
,S=C([S-])OC1CC2CC1C1CCCC21,,S=C([S-])O[C@H]1C[C@H]2C[C@@H]1[C@@H]1CCC[C@H]21,,SPK-601,,LOW,INACTIVE,3.91,-4.91,0
5067.0,CC(C)CC(NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O,,CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O,ixazomib,Ixazomib|MLN9708|IXAZOMIB CITRATE,,MODERATE,HIGH,2.06,-4.47,1
234.0,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)=O)C1c1ccccc1[N+](=O)[O-],,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)=O)C1c1ccccc1[N+](=O)[O-],aranidipine,Aranidipine,,HIGH,HIGH,2.21,-4.54,1
466.0,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O,,C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O,calcitriol,Calcitriol,"NCGC00161327-10, NCGC00161327-11",HIGH,HIGH,5.5,-4.81,1
,O=C1OC2(c3ccccc31)c1cc(I)c(O)c(I)c1Oc1c2cc(I)c(O)c1I,,O=C1OC2(c3ccccc31)c1cc(I)c(O)c(I)c1Oc1c2cc(I)c(O)c1I,,Erythrosin B,,HIGH,HIGH,4.87,-5.39,1
2748.0,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C,,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C,trimebutine,Trimebutine maleate,,LOW,INACTIVE,3.94,-4.32,0
1674.0,CCCCCC=CCC=CCCCCCCCC(=O)NC(C)c1ccccc1,,CCCCC/C=C\C/C=C\CCCCCCCC(=O)NC(C)c1ccccc1,melinamide,Melinamide,,MODERATE,LOW,8.2,-6.95,1
2332.0,CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,,CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,pyrimethamine,Pyrimethamine,NCGC00016256-20,LOW,INACTIVE,2.61,-3.14,0
,O=C(NO)c1cnc(NC2(c3ccccc3)CC2)nc1,,O=C(NO)c1cnc(NC2(c3ccccc3)CC2)nc1,,ACY-738,NCGC00511370-01,LOW,INACTIVE,1.22,-3.7,0
1613.0,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,loxapine,Loxapine succinate,,LOW,INACTIVE,3.19,-3.51,0
1646.0,CNC1(C)C2CCC(C2)C1(C)C,,CNC1(C)C2CCC(C2)C1(C)C,mecamylamine,Mecamylamine,,LOW,INACTIVE,3.13,-3.13,0
1321.0,COCCOc1cnc(NS(=O)(=O)c2ccccc2)nc1,,COCCOc1cnc(NS(=O)(=O)c2ccccc2)nc1,glymidine,Glymidine sodium,,LOW,INACTIVE,1.27,-3.4,0
,C(=Cc1ccncc1)c1ccccc1,,C(=C/c1ccncc1)\c1ccccc1,,4-Styrylpyridine,,LOW,MODERATE,3.03,-3.07,0
,COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n(C(C)c3ccccn3)c12,,COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12,,I-BET151,NCGC00344588-08,LOW,MODERATE,3.38,-3.65,0
4802.0,CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,,CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,trametinib,Trametinib,,MODERATE,LOW,3.45,-4.3,1
,CC1(C)CC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC(C)(C)N1,,CC1(C)CC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC(C)(C)N1,,NBD 556,,LOW,INACTIVE,2.47,-4.36,0
,c1ccc(CNc2nc(NCc3ccccc3)c3ccccc3n2)cc1,,c1ccc(CNc2nc(NCc3ccccc3)c3ccccc3n2)cc1,,KUC105555N,,MODERATE,HIGH,4.99,-5.19,1
,O=C1C(c2[nH]c3ccccc3c2O)=Nc2ccccc21,,O=C1C(c2[nH]c3ccccc3c2O)=Nc2ccccc21,,Indigo,,LOW,INACTIVE,3.28,-3.54,0
,Cc1cc(Nc2ccccc2C(=O)O)ccc1Cl,,Cc1cc(Nc2ccccc2C(=O)O)ccc1Cl,,2-[(4-Chloro-3-methylphenyl)amino]benzoic acid,,HIGH,HIGH,4.7,-4.25,1
4892.0,CCc1ccc(Cc2ccc3c(c2)C2(OC3)OC(CO)C(O)C(O)C2O)cc1,,CCc1ccc(Cc2ccc3c(c2)[C@]2(OC3)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1,tofogliflozin,Tofogliflozin (hydrate),,LOW,INACTIVE,1.5,-3.07,0
600.0,CC(=O)OC1(C(C)=O)CCC2C3C=C(Cl)C4=CC(=O)CCC4(C)C3CCC21C,,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,chlormadinone,Chlormadinone acetate,,HIGH,HIGH,3.58,-5.41,1
,CCCCCCCCOC(=O)c1cc(O)c(O)c(O)c1,,CCCCCCCCOC(=O)c1cc(O)c(O)c(O)c1,,Octyl gallate,,HIGH,HIGH,4.1,-3.04,1
,CCNC(=O)CC1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21,,CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21,,I-BET762,NCGC00263621-12,LOW,INACTIVE,2.52,-4.2,0
5150.0,CCCCCCCCCCCCCCCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,,CCCCCCCCCCCCCCCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1,chloramphenicol palmitate,Chloramphenicol palmitate,,HIGH,HIGH,7.04,-6.8,1
1659.0,CC(=O)OC1(C(C)=O)CCC2C3CC(C)C4=CC(=O)CCC4(C)C3CCC21C,,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,medroxyprogesterone,Medroxyprogesterone acetate|Medroxyprogesterone,NCGC00022037-07,LOW,INACTIVE,3.43,-5.24,0
2758.0,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,trimipramine,Trimipramine maleate,,LOW,INACTIVE,4.78,-4.05,0
2452.0,CC(C)(C)C(=O)Oc1ccc(S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)O)cc1,,CC(C)(C)C(=O)Oc1ccc(S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)O)cc1,sivelestat,Sivelestat sodium hydrate,,LOW,INACTIVE,2.55,-4.46,0
,CC(C)CC(NC(Cc1cncn1Cc1cc(Cl)cc(Cl)c1)C(=O)O)C(=O)O,,CC(C)C[C@H](N[C@@H](Cc1cncn1Cc1cc(Cl)cc(Cl)c1)C(=O)O)C(=O)O,,,NCGC00244248-01,MODERATE,LOW,1.63,-4.37,1
,CC1(C)CCC2(C(=O)O)CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C)C5CCC43C)C2C1,,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,,Maslinic acid,,HIGH,LOW,6.06,-5.1,1
,O=C(NN=Cc1ccc(O)c(O)c1)c1cc2ccccc2cc1O,,O=C(N/N=C/c1ccc(O)c(O)c1)c1cc2ccccc2cc1O,,Dynasore,,HIGH,HIGH,3.53,-4.0,1
,NS(=O)(=O)c1ccc(NC(=O)Nc2ccc(F)cc2)cc1,,NS(=O)(=O)c1ccc(NC(=O)Nc2ccc(F)cc2)cc1,,U-104,,LOW,INACTIVE,1.95,-3.29,0
416.0,CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1,,CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1,buclizine,Buclizine HCl,,MODERATE,LOW,6.16,-6.25,1
2586.0,CCOC(=O)C(CCc1ccccc1)NC1CSC(c2cccs2)CN(CC(=O)O)C1=O,,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CS[C@H](c2cccs2)CN(CC(=O)O)C1=O,temocapril,Temocapril hydrochloride,NCGC00181345-01,LOW,MODERATE,2.54,-5.14,0
73.0,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,acepromazine,Acetopromazine maleate,,LOW,INACTIVE,4.32,-4.52,0
,Cc1cccc(C=NNc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1,,Cc1cccc(/C=N/Nc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1,,Apilimod mesylate,NCGC00263093-04,HIGH,HIGH,3.91,-4.18,1
674.0,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,clevidipine,Clevidipine,,MODERATE,HIGH,4.32,-5.23,1
4801.0,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,dabrafenib,Dabrafenib,NCGC00346716-20,HIGH,HIGH,5.44,-5.22,1
3546.0,Cc1cc(O)c2c(c1)OC1(C)CCC3C(C)(C)CCCC34COC2C14,,Cc1cc(O)c2c(c1)O[C@@]1(C)CC[C@H]3C(C)(C)CCC[C@]34CO[C@@H]2[C@@H]14,siccanin,Siccanin,,MODERATE,LOW,4.79,-5.45,1
2078.0,CC(C)(C)NCC(O)COc1ccccc1C1CCCC1,,CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1,penbutolol,Penbutolol sulfate,,LOW,INACTIVE,3.85,-4.14,0
3066.0,CNC(=O)Oc1cccc2ccccc12,,CNC(=O)Oc1cccc2ccccc12,carbaryl,Carbaryl,,LOW,MODERATE,2.45,-3.34,0
1115.0,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,etravirine,Etravirine|Etravirine (TMC125),,LOW,INACTIVE,3.66,-4.41,0
,COc1cc2c(c(OC)c1OC)-c1c(cc3c(c1OC)OCO3)CC(C)C(C)(O)C2,,COc1cc2c(c(OC)c1OC)-c1c(cc3c(c1OC)OCO3)CC(C)C(C)(O)C2,,Schisandrol B,,LOW,INACTIVE,3.37,-4.2,0
,Cc1oc(-c2ccccc2)nc1CCOc1ccc(CC2C(=O)NOC2=O)cc1,,Cc1oc(-c2ccccc2)nc1CCOc1ccc(CC2C(=O)NOC2=O)cc1,,JTT-501,,HIGH,HIGH,3.85,-4.2,1
1886.0,CC(C)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)O)CC1,,CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1,nateglinide,NATEGLINIDE,NCGC00271534-03,LOW,INACTIVE,3.59,-4.57,0
4299.0,CC(C)c1nc(CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,cobicistat,Cobicistat,,MODERATE,HIGH,4.35,-5.79,1
1769.0,CCC(=O)OC1(C(=O)COC(C)=O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3C(O)CC21C,,CCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,methylprednisolone aceponate,Methylprednisolone aceponate,,LOW,INACTIVE,2.92,-4.87,0
,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2,,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2,,Zanapezil fumerate,,MODERATE,LOW,5.16,-5.79,1
2193.0,CCCCCCCCCCCCCCCC(=O)OCCC1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,,CCCCCCCCCCCCCCCC(=O)OCCC1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,pipotiazine palmitate,Pipothiazine palmitate,,LOW,INACTIVE,8.46,-7.43,0
2318.0,CC(Cc1ccc2c(c1)OCO2)NCC(O)c1ccc(O)c(O)c1,,CC(Cc1ccc2c(c1)OCO2)NCC(O)c1ccc(O)c(O)c1,protokylol,,NCGC00274276-01,HIGH,HIGH,1.4,-3.15,1
4819.0,CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,,C[C@]1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,delamanid,Delamanid,,HIGH,HIGH,5.71,-5.38,1
,O=C(C=Cc1ccc(O)c2c1C(C(=O)O)C(c1ccc(O)c(O)c1)O2)OC(Cc1ccc(O)c(O)c1)C(=O)O,,O=C(/C=C/c1ccc(O)c2c1[C@H](C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,,,NCGC00384596-01,HIGH,HIGH,3.58,-4.41,1
2749.0,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,alimemazine,Trimeprazine tartrate,,LOW,MODERATE,4.98,-4.55,0
,CC(CN1CCCC1)C(=O)c1ccc(C(F)(F)F)cc1,,C[C@H](CN1CCCC1)C(=O)c1ccc(C(F)(F)F)cc1,,Lanperisone hydrochloride,,LOW,INACTIVE,3.39,-3.92,0
1021.0,CC(=Cc1ccccc1)C=C1SC(=S)N(CC(=O)O)C1=O,,CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1,epalrestat,Epalrestat,NCGC00164613-04,HIGH,HIGH,3.09,-4.71,1
,CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(NC4CCC(O)CC4)c3)c2C1,,CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(NC4CCC(O)CC4)c3)c2C1,,SNX-2112,NCGC00346633-02,LOW,INACTIVE,3.32,-4.49,0
,CC(=O)c1cc([N+](=O)[O-])c(Sc2cccc(Cl)c2Cl)s1,,CC(=O)c1cc([N+](=O)[O-])c(Sc2cccc(Cl)c2Cl)s1,,P005091,,MODERATE,HIGH,4.72,-5.64,1
1992.0,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,ondansetron,Ondansetron,,LOW,INACTIVE,2.55,-3.08,0
1125.0,O=C1C(CCC(O)c2ccc(F)cc2)C(c2ccc(O)cc2)N1c1ccc(F)cc1,,O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1,ezetimibe,Ezetimibe,NCGC00263575-10,LOW,MODERATE,4.14,-4.69,0
,COC(=O)CCC(NC(=O)C(CC(=O)OC)NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(CC(=O)OC)C(=O)CF)C(C)C,,COC(=O)CC[C@H](NC(=O)[C@H](CC(=O)OC)NC(=O)OCc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)OC)C(=O)CF)C(C)C,,Z-DEVD-FMK,,LOW,INACTIVE,1.04,-4.36,0
3400.0,CCCCCCCCC=CCCCCCCCC(=O)O,,CCCCCCCC/C=C\CCCCCCCC(=O)O,oleic acid,Elaidic Acid,,HIGH,HIGH,7.68,-6.37,1
1993.0,OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1,,OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1,opipramol,Opipramol dihydrochloride,,LOW,MODERATE,3.21,-3.54,0
,CCCC(=O)Nc1c(I)cc(I)c(CC(CC)C(=O)[O-])c1I,,CCCC(=O)Nc1c(I)cc(I)c(CC(CC)C(=O)[O-])c1I,,Sodium tyropanoate,,LOW,INACTIVE,4.14,-5.3,0
2693.0,CCC1C(C)=NN=C(c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc21,,CCC1C(C)=NN=C(c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc21,tofisopam,Tofisopam,,LOW,INACTIVE,4.29,-5.2,0
4872.0,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1,,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1,ataluren,PTC-124,NCGC00168759-10,LOW,INACTIVE,2.98,-3.38,0
4168.0,O=C1C2C3CCC(C3)C2C(=O)N1CC1CCCCC1CN1CCN(c2nsc3ccccc23)CC1,,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1,lurasidone,Lurasidone (Hydrochloride),,LOW,INACTIVE,5.24,-4.79,0
,O=C(OC1Cc2c(O)cc(O)cc2OC1c1ccc(O)c(O)c1)c1cc(O)c(O)c(O)c1,,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1ccc(O)c(O)c1)c1cc(O)c(O)c(O)c1,,EPICATECHIN MONOGALLATE,,HIGH,HIGH,2.55,-4.0,1
865.0,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,diclofenac,Diclofenac sodium,,MODERATE,HIGH,4.96,-4.82,1
1373.0,CC(CNC1CCCCC1)OC(=O)c1ccccc1,,CC(CNC1CCCCC1)OC(=O)c1ccccc1,hexylcaine,Hexylcaine hydrochloride,,LOW,MODERATE,3.04,-4.43,0
3238.0,C=C1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(C)=O,,C=C1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O,fluprednidene acetate,Fluprednidene acetate,,LOW,INACTIVE,2.08,-4.18,0
4913.0,Cc1cnc(C(=O)NC2CCCCCC=CC3CC3(C(=O)NS(=O)(=O)C3CC3)NC(=O)C3CC(Oc4nc5ccccc5c5ccccc45)CN3C2=O)cn1,,Cc1cnc(C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@@]3(C(=O)NS(=O)(=O)C3CC3)NC(=O)[C@@H]3C[C@@H](Oc4nc5ccccc5c5ccccc45)CN3C2=O)cn1,paritaprevir,ABT-450|Paritaprevir,,MODERATE,HIGH,3.5,-5.01,1
2553.0,CN1CC(=O)N2C(Cc3c([nH]c4ccccc34)C2c2ccc3c(c2)OCO3)C1=O,,CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3c(c2)OCO3)C1=O,tadalafil,Tadalafil,NCGC00263909-08,LOW,INACTIVE,2.36,-3.19,0
765.0,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,cyproheptadine,Cyproheptadine hydrochloride,NCGC00015252-17,LOW,HIGH,5.02,-4.33,0
4504.0,CCCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,,CCCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,hydrocortisone valerate,Hydrocortisone valerate,,LOW,INACTIVE,3.62,-4.76,0
1235.0,CC(CN1c2ccccc2Sc2ccc(S(=O)(=O)N(C)C)cc21)N(C)C,,CC(CN1c2ccccc2Sc2ccc(S(=O)(=O)N(C)C)cc21)N(C)C,dimetotiazine,Fonazine,,HIGH,HIGH,3.47,-3.78,1
103.0,CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1,,CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1,albendazole,Albendazole,,LOW,INACTIVE,3.22,-4.06,0
,NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2,,NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2,,NMS-P118,NCGC00509914-01,LOW,INACTIVE,1.69,-3.28,0
860.0,CC(C)(C)c1ccc2c(S(=O)(=O)O)c(C(C)(C)C)ccc2c1,,CC(C)(C)c1ccc2c(S(=O)(=O)O)c(C(C)(C)C)ccc2c1,dibunate,DIBUNATE SODIUM,,MODERATE,LOW,2.48,-5.48,1
2811.0,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1,vecuronium,Vecuronium bromide,,LOW,INACTIVE,2.07,-7.5,0
,COc1ccc(Cn2ccc3ccc(C(=O)NO)cc32)cc1,,COc1ccc(Cn2ccc3ccc(C(=O)NO)cc32)cc1,,PCI-34051,,HIGH,HIGH,2.86,-3.92,1
1889.0,CCCc1c2oc(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)n(CC)c12,,CCCc1c2oc(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)n(CC)c12,nedocromil,Nedocromil,,LOW,INACTIVE,2.2,-3.91,0
893.0,COc1cc(C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC,,COc1cc(C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC,dilazep,Dilazep,,LOW,INACTIVE,3.2,-4.08,0
913.0,CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(=O)O,,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,dinoprostone,Prostaglandin E2,,LOW,INACTIVE,3.32,-3.92,0
,COc1ccc2ccc(=O)oc2c1CC=C(C)C,,COc1ccc2ccc(=O)oc2c1CC=C(C)C,,Ostol,,LOW,INACTIVE,3.41,-4.58,0
,O=C(OCc1ccccc1)c1ccc(O)cc1,,O=C(OCc1ccccc1)c1ccc(O)cc1,,Benzylparaben,,LOW,INACTIVE,3.66,-3.23,0
,CCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,,CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,,Testosterone decanoate,,LOW,INACTIVE,6.36,-6.59,0
2420.0,O=C(Oc1ccccc1C(=O)O)c1ccccc1O,,O=C(Oc1ccccc1C(=O)O)c1ccccc1O,salsalate,Salsalate,,LOW,INACTIVE,3.45,-3.02,0
465.0,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)C=CC(O)C2CC2)CC(O)CC1O,,C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@@H](O)C2CC2)C[C@@H](O)C[C@@H]1O,calcipotriene,Calcipotriene|Calcipotriol,,MODERATE,HIGH,4.6,-4.51,1
4507.0,CC1(C)OC2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)C2(C(=O)CCl)O1,,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1,halcinonide,Halcinonide,,LOW,MODERATE,3.32,-4.61,0
3412.0,COc1ccc(C(=O)c2ccccc2)c(O)c1,,COc1ccc(C(=O)c2ccccc2)c(O)c1,oxybenzone,2-Hydroxy-4-methoxybenzophenone,,LOW,INACTIVE,3.35,-3.25,0
2635.0,CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,,CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,thioproperazine,Thioproperazine dimethanesulfonate,,MODERATE,HIGH,3.09,-3.89,1
3128.0,O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1,,O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1,deferasirox,Deferasirox,NCGC00181754-07,LOW,MODERATE,4.0,-4.04,0
2865.0,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,ziprasidone,Ziprasidone,,HIGH,HIGH,4.63,-4.76,1
2651.0,CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC,,CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC,tiapride,Tiapride hydrochloride,,LOW,INACTIVE,1.03,-3.11,0
,CCOC(=O)c1cccc(CNc2ccc(N(C)C(=O)Nc3ccccc3)cc2)c1,,CCOC(=O)c1cccc(CNc2ccc(N(C)C(=O)Nc3ccccc3)cc2)c1,,GN6958,,HIGH,HIGH,4.5,-5.42,1
4228.0,CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O,,CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O,ivacaftor,Ivacaftor,NCGC00242480-02,HIGH,HIGH,5.0,-5.29,1
4875.0,COC(=O)NC(C(=O)N1CCCC1c1ncc(-c2ccc(-c3ccc(-c4cnc(C5CCCN5C(=O)C(NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C,,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C,daclatasvir,Daclatasvir dihydrochloride,NCGC00346533-13,HIGH,HIGH,4.67,-4.94,1
1457.0,Oc1c(I)cc(I)c2cccnc12,,Oc1c(I)cc(I)c2cccnc12,diiodohydroxyquinoline,Iodoquinol,,HIGH,HIGH,3.93,-3.69,1
1353.0,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,haloperidol,Haloperidol,,LOW,INACTIVE,3.7,-4.92,0
2827.0,CCC1=CC2CN(C1)Cc1c([nH]c3ccccc13)C(C(=O)OC)(c1cc3c(cc1OC)N(C)C1C(O)(C(=O)OC)C(OC(C)=O)C4(CC)C=CCN5CCC31C54)C2,,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,vinorelbine,Vinorelbine tartrate,NCGC00165966-05,MODERATE,MODERATE,4.39,-4.84,1
1676.0,Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,,Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,meloxicam,MELOXICAM SODIUM,NCGC00018248-18,LOW,INACTIVE,2.28,-3.36,0
,Cc1nnc2n1-c1sc(CCc3ccc(CC(C)C)cc3)cc1C(c1ccccc1Cl)=NC2C,,Cc1nnc2n1-c1sc(CCc3ccc(CC(C)C)cc3)cc1C(c1ccccc1Cl)=NC2C,,Israpafant,,HIGH,HIGH,5.75,-5.23,1
,NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(F)cc2)cc1,,NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(F)cc2)cc1,,Mavacoxib,,MODERATE,HIGH,3.83,-5.08,1
870.0,CC=C(C(=CC)c1ccc(O)cc1)c1ccc(O)cc1,,C/C=C(C(=C/C)/c1ccc(O)cc1)\c1ccc(O)cc1,dienestrol,Dienestrol,,LOW,MODERATE,5.2,-4.33,0
3514.0,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,quercetin,Quercetin,NCGC00015870-26,HIGH,HIGH,1.81,-3.06,1
,Cc1ccc(C(=O)NCCCCCC(=O)Nc2ccccc2N)cc1,,Cc1ccc(C(=O)NCCCCCC(=O)Nc2ccccc2N)cc1,,RG2833,,MODERATE,LOW,2.61,-5.05,1
2186.0,CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,,CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,piperacetazine,Piperacetazine,,MODERATE,HIGH,4.82,-5.16,1
1152.0,CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,,CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,fenofibrate,Fenofibrate,NCGC00015437-22,LOW,INACTIVE,4.86,-5.71,0
2181.0,NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,,NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,pipamperone,Pipamperone dihydrochloride,,LOW,INACTIVE,2.32,-3.31,0
,COC(=O)C(CCSC)NC(=O)c1ccc(NCC(N)CS)cc1-c1ccccc1,,COC(=O)[C@H](CCSC)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1,,FTI-277 hydrochloride,,HIGH,HIGH,3.4,-5.14,1
2357.0,Cn1cc(C(=O)C2CCc3nc[nH]c3C2)c2ccccc21,,Cn1cc(C(=O)[C@@H]2CCc3nc[nH]c3C2)c2ccccc21,ramosetron,Ramosetron hydrochloride,,MODERATE,HIGH,2.24,-3.61,1
,CCOc1ccc2ccccc2c1C(=O)NC1C(=O)N2C1SC(C)(C)C2C(=O)[O-],,CCOc1ccc2ccccc2c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12,,Nafcillin sodium monohydrate,,LOW,INACTIVE,3.21,-4.38,0
,O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2Cl)nc1)NO,,O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2Cl)nc1)NO,,ACY-241,,MODERATE,LOW,3.61,-4.69,1
,CC(=O)C=CC=C1C2CCC(C2)C1(C)C,,CC(=O)/C=C/C=C1/C2CCC(C2)C1(C)C,,Bornelone,,LOW,INACTIVE,4.59,-4.1,0
,CC(C)(C)c1cc(C(=O)C(C#N)=NNc2cccc(Cl)c2)no1,,CC(C)(C)c1cc(C(=O)/C(C#N)=N/Nc2cccc(Cl)c2)no1,,ESI-09,,HIGH,HIGH,5.09,-3.5,1
1419.0,CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1,,CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1,ifenprodil,Ifenprodil,,LOW,INACTIVE,3.98,-3.49,0
,CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(C)c(Cl)c2)CC1,,CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(C)c(Cl)c2)CC1,,TAK-220,,LOW,INACTIVE,4.44,-5.36,0
1932.0,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,nilotinib,Nilotinib,NCGC00183285-06,MODERATE,HIGH,4.51,-5.42,1
,CCCCCCCCCCCCCCCc1cccc(O)c1C(=O)O,,CCCCCCCCCCCCCCCc1cccc(O)c1C(=O)O,,AnacardicAcid,,HIGH,HIGH,8.13,-6.06,1
,C=C(C)C1CCC2(C(=O)O)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC43C)C12,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,,Betulinic acid,,LOW,INACTIVE,5.34,-6.35,0
4914.0,COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C,,COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C,dasabuvir,ABT-333,,HIGH,HIGH,4.7,-5.79,1
2767.0,Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,,Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,troglitazone,Troglitazone,NCGC00161599-13,HIGH,HIGH,4.16,-5.56,1
4682.0,Cc1[nH]c2ccccc2c1CCNCc1ccc(C=CC(=O)NO)cc1,,Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1,panobinostat,Panobinostat,NCGC00263117-22,HIGH,HIGH,3.16,-5.25,1
,CC(COc1ccc(Oc2ccccc2)cc1)Oc1ccccn1,,C[C@@H](COc1ccc(Oc2ccccc2)cc1)Oc1ccccn1,,,NCGC00164462-05,HIGH,HIGH,4.9,-4.3,1
1637.0,CC(Cc1ccc(O)c(O)c1)C(C)Cc1ccc(O)c(O)c1,,C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1,masoprocol,"4,4 -(2,3-Dimethyltetramethylene)dipyrocatechol",NCGC00094201-03,HIGH,HIGH,3.44,-4.35,1
5064.0,CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1,,CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1,climbazole,Climbazole,,LOW,INACTIVE,3.33,-3.69,0
,COCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1C,,COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C,,Vicriviroc (SCH-417690),,LOW,INACTIVE,3.28,-4.17,0
,O=C(Nc1ccc([N+](=O)[O-])cc1)Nc1ccc([N+](=O)[O-])cc1,,O=C(Nc1ccc([N+](=O)[O-])cc1)Nc1ccc([N+](=O)[O-])cc1,,"4,4'-Dinitrodiphenylurea",,LOW,INACTIVE,2.48,-4.41,0
4993.0,CNCc1cc(-c2ccccc2F)n(S(=O)(=O)c2cccnc2)c1,,CNCc1cc(-c2ccccc2F)n(S(=O)(=O)c2cccnc2)c1,vonoprazan,TAK 438,,LOW,INACTIVE,1.76,-3.85,0
2590.0,COc1cc(C2c3cc4c(cc3C(OC3OC5COC(c6cccs6)OC5C(O)C3O)C3COC(=O)C23)OCO4)cc(OC)c1O,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](c6cccs6)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,teniposide,TENIPOSIDE,NCGC00346563-03,HIGH,HIGH,1.67,-4.04,1
5214.0,CCOC(=O)C(N)Cc1ccc(-c2cc(OC(c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1,,CCOC(=O)[C@@H](N)Cc1ccc(-c2cc(O[C@H](c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1,telotristat ethyl,LX1606 (Hippurate),NCGC00390241-09,HIGH,HIGH,5.34,-5.29,1
3825.0,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)C=Cc2ccc(O)c(OC)c2)C1OC,,COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2ccc(O)c(OC)c2)[C@@H]1OC,rescimetol,Rescimetol,,HIGH,HIGH,3.98,-4.81,1
,COc1cc2c(c(OC)c1OC)-c1c(cc(OC)c(OC)c1OC)CC(C)C(C)C2,,COc1cc2c(c(OC)c1OC)-c1c(cc(OC)c(OC)c1OC)CC(C)C(C)C2,,,NCGC00163662-01,LOW,INACTIVE,4.82,-5.26,0
2090.0,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,pentamidine,Pentamidine isethionate,NCGC00179034-15,LOW,INACTIVE,1.31,-4.18,0
,N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCCCc1ccccc1,,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCc1ccccc1,,Tyrphostin AG 555,,HIGH,HIGH,2.96,-4.42,1
2370.0,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,,COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC,reserpine,Reserpine,NCGC00015888-06,HIGH,HIGH,4.06,-4.75,1
,CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1,,CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,,Calpeptin,NCGC00163432-03,LOW,INACTIVE,2.71,-4.46,0
,CCCCCCCCCCCCOCCO,,CCCCCCCCCCCCOCCO,,2-(Dodecyloxy)ethanol,,LOW,INACTIVE,5.15,-5.09,0
,O=c1cc(-c2ccc(O)cc2)oc2cc(O)c(O)c(O)c12,,O=c1cc(-c2ccc(O)cc2)oc2cc(O)c(O)c(O)c12,,Scutellarein,,MODERATE,LOW,2.74,-3.26,1
,CC(C)C(NC(=O)c1ccc2ccccc2n1)C(=O)NC(CC(=O)O)C(=O)COc1c(F)cccc1F,,CC(C)[C@H](NC(=O)c1ccc2ccccc2n1)C(=O)N[C@@H](CC(=O)O)C(=O)COc1c(F)cccc1F,,Q-VD-OPh hydrate,,HIGH,LOW,2.91,-5.04,1
,COP(=S)(OC)Oc1ccc(S(=O)(=O)N(C)C)cc1,,COP(=S)(OC)Oc1ccc(S(=O)(=O)N(C)C)cc1,,Famphur,,LOW,INACTIVE,2.15,-3.15,0
2276.0,OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1,,OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1,procyclidine,Procyclidine hydrochloride,,LOW,INACTIVE,4.13,-4.47,0
,Fc1ccc(CNc2ncnc3ccc(F)cc23)cc1,,Fc1ccc(CNc2ncnc3ccc(F)cc23)cc1,,Spautin-1,NCGC00263555-05,LOW,INACTIVE,3.26,-4.16,0
2110.0,OC(CN1CCCCC1)c1cc(-c2ccccc2)on1,,OC(CN1CCCCC1)c1cc(-c2ccccc2)on1,perisoxal,Perisoxal citrate,,LOW,INACTIVE,2.63,-3.11,0
3658.0,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,xylometazoline,Xylometazoline hydrochloride,NCGC00016101-17,LOW,INACTIVE,4.68,-4.44,0
3959.0,CCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,,CCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,hydrocortisone butyrate,Hydrocortisone 17-butyrate,,LOW,INACTIVE,3.21,-4.5,0
4727.0,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCC(O)C(C)C)CC(O)CC1O,,C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CC[C@@H](O)C(C)C)C[C@@H](O)C[C@@H]1O,tacalcitol,Tacalcitol,,HIGH,LOW,5.35,-4.62,1
881.0,CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CCC5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1O,,C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,digitoxin,DIGITOXIN,,LOW,INACTIVE,2.33,-4.42,0
1649.0,Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1,,Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1,meclozine,Meclizine hydrochloride,NCGC00018296-15,LOW,MODERATE,5.59,-5.58,0
203.0,COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12,,COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12,amsacrine,Amsacrine,NCGC00093644-09,MODERATE,HIGH,4.67,-5.09,1
3759.0,Nc1c(I)cc(I)c(C(=O)N(CCC(=O)O)c2ccccc2)c1I,,Nc1c(I)cc(I)c(C(=O)N(CCC(=O)O)c2ccccc2)c1I,iobenzamic acid,Iobenzamic acid,,MODERATE,LOW,3.46,-4.85,1
,FC(F)(F)c1cccc(C2=CCN(CCc3ccc4ccccc4c3)CC2)c1,,FC(F)(F)c1cccc(C2=CCN(CCc3ccc4ccccc4c3)CC2)c1,,Xaliproden hydrochloride,,LOW,INACTIVE,6.26,-6.22,0
1890.0,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1,,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1,nefazodone,Nefazodone hydrochloride,,MODERATE,LOW,3.7,-3.83,1
1153.0,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,fenoldopam,Fenoldopam,NCGC00015444-10,LOW,INACTIVE,2.38,-3.05,0
4816.0,OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2,,OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2,umeclidinium,Umeclidinium bromide,,LOW,INACTIVE,2.88,-7.38,0
2680.0,CCCCS(=O)(=O)NC(Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O,,CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O,tirofiban,Tirofiban hydrochloride monohydrate,,LOW,INACTIVE,1.83,-5.14,0
,O=C(c1ccccc1)c1ccc2nc(NC(=O)c3csc(C4CCN(c5ncnc6ccsc56)CC4)n3)[nH]c2c1,,O=C(c1ccccc1)c1ccc2nc(NC(=O)c3csc(C4CCN(c5ncnc6ccsc56)CC4)n3)[nH]c2c1,,SC75741,,HIGH,HIGH,5.05,-5.26,1
2044.0,CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)c2ccccc2)C2(O)CC(OC(=O)C(O)C(NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,paclitaxel,Paclitaxel,NCGC00024995-15,MODERATE,HIGH,3.2,-5.19,1
,COc1ccc2c(c1)c(CC(=O)OCC=C(C)CCC=C(C)CCC=C(C)C)c(C)n2C(=O)c1ccc(Cl)cc1,,COc1ccc2c(c1)c(CC(=O)OC/C=C(\C)CC/C=C(\C)CCC=C(C)C)c(C)n2C(=O)c1ccc(Cl)cc1,,Indomethacin farnesil,,LOW,INACTIVE,7.6,-7.12,0
2737.0,CC[N+](CC)(CC)CCC(O)(c1ccccc1)C1CCCCC1,,CC[N+](CC)(CC)CCC(O)(c1ccccc1)C1CCCCC1,tridihexethyl,Tridihexethyl chloride,,LOW,INACTIVE,2.31,-7.32,0
,NC(=O)c1noc(C(CCCC2CCCCC2)CC(=O)NO)n1,,NC(=O)c1noc([C@H](CCCC2CCCCC2)CC(=O)NO)n1,,UK-383367,,LOW,INACTIVE,2.41,-3.46,0
,COc1ccc(-c2oc3cc(OC)c(OC)c(O)c3c(=O)c2OC)cc1O,,COc1ccc(-c2oc3cc(OC)c(OC)c(O)c3c(=O)c2OC)cc1O,,Casticin,,MODERATE,HIGH,2.71,-3.9,1
4496.0,CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,,CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,haloperidol decanoate,HALOPERIDOL DECANOATE,,LOW,INACTIVE,7.22,-6.97,0
,NC(=NN=Cc1ccc(Cl)cc1)NN=Cc1ccc(Cl)cc1,,N/C(=N\N=C\c1ccc(Cl)cc1)N/N=C/c1ccc(Cl)cc1,,Robenidine,,HIGH,HIGH,2.17,-4.78,1
4334.0,Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12,,Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12,bazedoxifene,Bazedoxifene,NCGC00182055-09,HIGH,HIGH,6.04,-5.92,1
3300.0,CC1(C)C(=CC=CC=CC=CC2=[N+](CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)N(CCCCS(=O)(=O)O)c2ccc3ccccc3c21,,CC1(C)C(=CC=CC=CC=CC2=[N+](CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)N(CCCCS(=O)(=O)O)c2ccc3ccccc3c21,indocyanine green,INDOCYANINE GREEN,,HIGH,HIGH,2.26,-7.31,1
,Cn1c(N2CCCCS2(=O)=O)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,,Cn1c(N2CCCCS2(=O)=O)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O,,BMS-707035,,LOW,INACTIVE,1.13,-4.0,0
4382.0,Nc1nc(CC(=O)Nc2ccc(CCNCC(O)c3ccccc3)cc2)cs1,,Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1,mirabegron,Mirabegron,,HIGH,HIGH,2.2,-4.98,1
2411.0,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c([N+](=O)[O-])cccc3nc2-1,,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c([N+](=O)[O-])cccc3nc2-1,rubitecan,Rubitecan,,MODERATE,LOW,1.88,-3.22,1
,CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2C(Nc2ccc(Cl)cc2)CC1C,,CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C,,GSK1324726A,NCGC00356069-03,MODERATE,HIGH,5.12,-5.78,1
847.0,CC12CCCCCC(Cc3ccc(O)cc31)C2N,,C[C@@]12CCCCC[C@@H](Cc3ccc(O)cc31)[C@@H]2N,dezocine,,NCGC00274273-01,LOW,INACTIVE,3.76,-4.24,0
2723.0,COc1cc(CC2NCCc3cc(O)c(O)cc32)cc(OC)c1OC,,COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC,tretoquinol,Trimethoquinol,,LOW,INACTIVE,2.23,-3.55,0
2065.0,C#CCN(C)Cc1ccccc1,,C#CCN(C)Cc1ccccc1,pargyline,Pargyline hydrochloride,,LOW,INACTIVE,2.05,-3.2,0
1209.0,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,fluoxetine,(+/-) -Fluoxetine,,LOW,INACTIVE,4.1,-5.26,0
,O=C(NC(=O)c1c(F)cccc1F)Nc1cc(Cl)c(OC(F)(F)C(F)C(F)(F)F)cc1Cl,,O=C(NC(=O)c1c(F)cccc1F)Nc1cc(Cl)c(OC(F)(F)C(F)C(F)(F)F)cc1Cl,,Lufenuron,,LOW,MODERATE,6.04,-5.58,0
,[N-]=[N+]=NCc1cccc(C(O)=CC(=O)C(=O)O)c1,,[N-]=[N+]=NCc1cccc(/C(O)=C/C(=O)C(=O)O)c1,,HIV-1 integrase inhibitor,,HIGH,LOW,2.37,-3.27,1
1902.0,CCCCCOc1ccccc1C(=CSC)n1ccnc1,,CCCCCOc1ccccc1/C(=C\SC)n1ccnc1,neticonazole,Neticonazole,,HIGH,HIGH,4.91,-4.46,1
2342.0,C#CC1(O)CCC2C3CCc4cc(OC5CCCC5)ccc4C3CCC21C,,C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC5CCCC5)ccc4[C@H]3CC[C@@]21C,quinestrol,Quinestrol,,MODERATE,MODERATE,5.28,-5.37,1
2541.0,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,sultopride,Sultopride hydrochloride,,LOW,INACTIVE,1.54,-3.25,0
5133.0,CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1,,CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1,venetoclax,Venetoclax (ABT-199),NCGC00345789-16,HIGH,HIGH,6.92,-5.98,1
2448.0,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,sitagliptin,Sitagliptin,NCGC00178734-10,LOW,INACTIVE,1.95,-4.08,0
,C=CC(C)(C)c1cc(C=CC(=O)c2ccc(O)cc2)c(OC)cc1O,,C=CC(C)(C)c1cc(/C=C/C(=O)c2ccc(O)cc2)c(OC)cc1O,,Licochalcone A,,HIGH,HIGH,4.74,-4.63,1
4647.0,CC(=O)OC1(C(C)=O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,fluorometholone acetate,Fluorometholone Acetate,,LOW,INACTIVE,2.76,-4.82,0
4554.0,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)SCF,,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF,fluticasone furoate,Fluticasone furoate,,LOW,INACTIVE,3.73,-4.09,0
658.0,CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O,,CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O,ciprofibrate,Ciprofibrate,NCGC00015202-21,LOW,INACTIVE,3.96,-4.57,0
2063.0,CCC(=O)NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1,,CCC(=O)NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1,parecoxib,Parecoxib,,LOW,INACTIVE,3.42,-4.36,0
4899.0,COC(=O)NC(C(=O)N1CC2(CC2)CC1c1nc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5[nH]c(C6C7CCC(C7)N6C(=O)C(NC(=O)OC)C(C)C)nc5c4)ccc2-3)c[nH]1)C(C)C,,COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1nc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5[nH]c([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5c4)ccc2-3)c[nH]1)C(C)C,ledipasvir,Ledipasvir (GS 5885)|Ledipasvir (D-tartrate),,HIGH,HIGH,5.98,-5.36,1
5243.0,CC(C)(C)C1NC(=O)OC2CCCC2OCC=CC(F)(F)c2nc3ccccc3nc2OC2CC(C(=O)NC3(C(=O)NS(=O)(=O)C4(C)CC4)CC3C(F)F)N(C2)C1=O,,CC(C)(C)[C@@H]1NC(=O)O[C@@H]2CCC[C@H]2OC/C=C/C(F)(F)c2nc3ccccc3nc2O[C@@H]2C[C@@H](C(=O)N[C@]3(C(=O)NS(=O)(=O)C4(C)CC4)C[C@H]3C(F)F)N(C2)C1=O,glecaprevir,Glecaprevir,,MODERATE,HIGH,4.27,-4.3,1
,Cc1c(Nc2ncccc2C(=O)O)cccc1C(F)(F)F,,Cc1c(Nc2ncccc2C(=O)O)cccc1C(F)(F)F,,Flunixin meglumine,,LOW,MODERATE,4.35,-3.88,0
,C=CC=CCC1=C(C)C(OC(=O)C2C(C=C(C)C)C2(C)C)CC1=O,,C=C/C=C\CC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](C=C(C)C)C2(C)C)CC1=O,,Pyrethrin 1,,MODERATE,LOW,5.11,-4.61,1
4628.0,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,enzalutamide,Enzalutamide,,MODERATE,HIGH,3.74,-5.52,1
5330.0,O=C(C=Cn1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1cnccn1,,O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1cnccn1,selinexor,Selinexor,NCGC00386310-03,MODERATE,LOW,2.85,-4.9,1
2120.0,Nc1ccc(N=Nc2ccccc2)c(N)n1,,Nc1ccc(/N=N/c2ccccc2)c(N)n1,phenazopyridine,Phenazopyridine hydrochloride|PHENAZOPYRIDINE HYDROCHLORIDE,,HIGH,HIGH,2.31,-3.02,1
2179.0,CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,,CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,pioglitazone,Pioglitazone hydrochloride,NCGC00163128-17,MODERATE,LOW,3.16,-4.91,1
2284.0,CN(C)CCCN1c2ccccc2Sc2ccccc21,,CN(C)CCCN1c2ccccc2Sc2ccccc21,promazine,Promazine hydrochloride|PROMAZINE HYDROCHLORIDE,,MODERATE,HIGH,4.72,-4.14,1
404.0,CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1,,CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1,bromazine,Bromodiphenhydramine,,LOW,INACTIVE,4.16,-4.99,0
1934.0,COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,,COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,nilvadipine,Nilvadipine,,MODERATE,HIGH,2.77,-4.49,1
4907.0,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,olaparib,Olaparib,NCGC00238451-09,LOW,INACTIVE,2.72,-3.86,0
2124.0,CC(Oc1ccccc1)C(=O)NC1C(=O)N2C1SC(C)(C)C2C(=O)O,,CC(Oc1ccccc1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,pheneticillin,Phenethicillin potassium salt,,LOW,INACTIVE,2.22,-3.01,0
3539.0,O=C(Nc1ccccc1)c1ccccc1O,,O=C(Nc1ccccc1)c1ccccc1O,salicylanilide,Salicylanilide,,LOW,INACTIVE,2.65,-3.17,0
4053.0,CC1NCc2cc(-c3ccc4c(=O)c(C(=O)O)cn(C5CC5)c4c3OC(F)F)ccc21,,C[C@H]1NCc2cc(-c3ccc4c(=O)c(C(=O)O)cn(C5CC5)c4c3OC(F)F)ccc21,garenoxacin,Garenoxacin mesylate hydrate,,HIGH,HIGH,1.89,-4.27,1
3424.0,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,pentazocine,(+)-Pentazocine succinate,,LOW,INACTIVE,4.45,-3.37,0
4173.0,CCCC(NC(=O)C1C2CCCC2CN1C(=O)C(NC(=O)C(NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1,,CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1,telaprevir,Telaprevir (VX-950),,HIGH,HIGH,2.56,-4.28,1
2432.0,CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O,,CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O,seratrodast,Seratrodast,NCGC00181296-08,HIGH,HIGH,3.35,-4.99,1
784.0,NC(=O)C(c1ccccc1)(c1ccccc1)C1CCN(CCc2ccc3c(c2)CCO3)C1,,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1,darifenacin,Darifenacin hydrobromide,,LOW,INACTIVE,4.35,-6.16,0
4681.0,CC12CCC3C4CCC(=O)C(O)=C4CCC3C1CCC2OC(=O)CCC1CCCC1,,C[C@]12CC[C@@H]3[C@H]4CCC(=O)C(O)=C4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1,oxabolone cipionate,Oxabolone cipioncate,,LOW,INACTIVE,4.43,-5.05,0
2769.0,COC1CC(OC2C(C)C(=O)OC(C)C(C)C(OC(C)=O)C(C)C(=O)C3(CO3)CC(C)C(OC3OC(C)CC(N(C)C)C3OC(C)=O)C2C)OC(C)C1OC(C)=O,,CO[C@H]1C[C@H](O[C@@H]2[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](OC(C)=O)[C@@H](C)C(=O)[C@]3(CO3)C[C@H](C)[C@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3OC(C)=O)[C@H]2C)O[C@@H](C)[C@@H]1OC(C)=O,troleandomycin,Troleandomycin,,LOW,HIGH,3.75,-4.63,0
4189.0,CCCCCC(=O)OC1(C(C)=O)CCC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,,CCCCCC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,hydroxyprogesterone caproate,Hydroxyprogesterone caproate,,LOW,INACTIVE,4.81,-5.7,0
,C(=NNc1nc(Nc2ccccc2)nc(N2CCOCC2)n1)c1c[nH]c2ccccc12,,C(=N/Nc1nc(Nc2ccccc2)nc(N2CCOCC2)n1)\c1c[nH]c2ccccc12,,MLS000543798-03,,HIGH,HIGH,4.34,-4.13,1
,CC(C)NC(C)Cc1ccc(I)cc1,,CC(C)NC(C)Cc1ccc(I)cc1,,Iofetamine hydrochloride,,LOW,INACTIVE,3.57,-4.78,0
1872.0,CN(CC=Cc1ccccc1)Cc1cccc2ccccc12,,CN(C/C=C/c1ccccc1)Cc1cccc2ccccc12,naftifine,Naftifine hydrochloride,,HIGH,HIGH,4.97,-6.1,1
3194.0,CCOc1ccc2nc3cc(N)ccc3c(N)c2c1,,CCOc1ccc2nc3cc(N)ccc3c(N)c2c1,ethacridine,Ethacridine lactate hydrate,,HIGH,HIGH,2.49,-3.58,1
,COC1CCN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)CC1,,COC1CCN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)CC1,,AZD-2461,NCGC00381558-06,LOW,INACTIVE,2.98,-4.17,0
4303.0,CC(=O)OC1Cc2ccccc2N(C(N)=O)c2ccccc21,,CC(=O)O[C@H]1Cc2ccccc2N(C(N)=O)c2ccccc21,eslicarbazepine acetate,Eslicarbazepine (acetate),,LOW,INACTIVE,1.99,-3.43,0
684.0,CC(Cc1ccccc1)NCc1ccccc1Cl,,C[C@@H](Cc1ccccc1)NCc1ccccc1Cl,clobenzorex,Clobenzorex hydrochloride,,LOW,INACTIVE,4.27,-5.39,0
,CCCCCCC(O)CC=CCCCCCCCC(=O)[O-],,CCCCCC[C@@H](O)C/C=C\CCCCCCCC(=O)[O-],,Potassium ricinoleate,,LOW,INACTIVE,6.14,-5.08,0
,C=CCNc1c(O)cc2c(O)c1CC(C)CC(OC)C(O)C(C)C=C(C)C(OC(N)=O)C(OC)C=CC=C(C)C(=O)N2,,C=CCNc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)N2,,Retaspimycin (Hydrochloride),NCGC00346438-02,HIGH,HIGH,3.96,-4.53,1
3487.0,CCCCOc1ccc(OCCCN2CCOCC2)cc1,,CCCCOc1ccc(OCCCN2CCOCC2)cc1,pramocaine,Pramoxine hydrochloride,,LOW,INACTIVE,3.02,-3.12,0
63.0,CC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I,,CC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I,acetrizoic acid,Acetrizoic acid,,LOW,INACTIVE,3.03,-4.0,0
,COc1c(O)cc2oc(-c3ccccc3)cc(=O)c2c1O,,COc1c(O)cc2oc(-c3ccccc3)cc(=O)c2c1O,,Oroxylin A,,HIGH,HIGH,3.47,-3.63,1
3659.0,COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC21,,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21,yohimbine,Yohimbine,NCGC00025018-11,LOW,INACTIVE,2.36,-3.01,0
,O=C(CCCCCCC(=O)NN=Cc1ccc(N(c2ccccc2)c2ccccc2)cc1)NO,,O=C(CCCCCCC(=O)N/N=C/c1ccc(N(c2ccccc2)c2ccccc2)cc1)NO,,WT-161,,HIGH,HIGH,4.98,-5.79,1
,OC(COc1cccc2ncccc12)CN1CCN(C2c3ccccc3C3C(c4ccccc42)C3(F)F)CC1,,O[C@@H](COc1cccc2ncccc12)CN1CCN(C2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1,,Zosuquidar trihydrochloride,,HIGH,HIGH,5.17,-4.74,1
1601.0,Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)CC(Cc1ccccc1)NC(=O)C(C(C)C)N1CCCNC1=O,,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,lopinavir,Lopinavir,,MODERATE,HIGH,3.88,-5.51,1
5020.0,CCCCCCCCNC(=N)NC(=N)NCc1ccc(Cl)c(Cl)c1,,CCCCCCCCNC(=N)NC(=N)NCc1ccc(Cl)c(Cl)c1,olanexidine,,NCGC00538147-01,LOW,MODERATE,3.93,-4.45,0
5155.0,CCC1C(O)C2C3CCC(C(C)CCC(=O)O)C3(C)CCC2C2(C)CCC(O)CC12,,CC[C@@H]1[C@@H]2C[C@H](O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]3[C@H](C)CCC(=O)O)[C@@H]2[C@@H]1O,obeticholic acid,INT-747 (Obeticholic acid),,MODERATE,LOW,3.5,-4.62,1
3108.0,O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1,,O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1,halocarban,Cloflucarban,,LOW,INACTIVE,4.98,-5.56,0
,O=C(CCCN1CCN(c2ccc(F)cc2)CC1)NC1c2ccccc2CSc2ccccc21,,O=C(CCCN1CCN(c2ccc(F)cc2)CC1)NC1c2ccccc2CSc2ccccc21,,Monatepil,,LOW,HIGH,5.04,-5.59,0
517.0,NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccccc32)CC1,,NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccccc32)CC1,carpipramine,Carpipramine Dihydrochloride,,MODERATE,LOW,4.8,-4.61,1
,CC(NC(=O)C(=O)Nc1ccccc1C(C)(C)C)C(=O)NC(CC(=O)O)C(=O)COc1c(F)c(F)cc(F)c1F,,C[C@H](NC(=O)C(=O)Nc1ccccc1C(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)COc1c(F)c(F)cc(F)c1F,,Emricasan,,LOW,INACTIVE,3.48,-5.43,0
,Cn1cncc1C(N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C,,Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C,,Tipifarnib,NCGC00250406-03,HIGH,HIGH,4.78,-6.01,1
1205.0,CC(=O)OCC(=O)C12OC(C)(C)OC1CC1C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C,,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,fluocinonide,Fluocinonide,NCGC00022398-13,MODERATE,LOW,2.93,-4.47,1
,CCC(NC(=O)C(C)NC)C(=O)N1CC(O)CC1Cc1c(-c2[nH]c3cc(F)ccc3c2CC2CC(O)CN2C(=O)C(CC)NC(=O)C(C)NC)[nH]c2cc(F)ccc12,,CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c(-c2[nH]c3cc(F)ccc3c2C[C@@H]2C[C@H](O)CN2C(=O)[C@H](CC)NC(=O)[C@H](C)NC)[nH]c2cc(F)ccc12,,Birinapant,,MODERATE,HIGH,2.21,-4.36,1
4889.0,C=CC1CC1(NC(=O)C1CC(Oc2ncc(OC)c3ccc(Cl)cc23)CN1C(=O)C(NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2ncc(OC)c3ccc(Cl)cc23)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,asunaprevir,Asunaprevir (BMS-650032),,LOW,INACTIVE,3.26,-5.4,0
1061.0,CCCCCCC(=O)OC1CCC2C3CCc4cc(O)ccc4C3CCC12C,,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C,estradiol enanthate,Estradiol enanthate,,MODERATE,HIGH,6.45,-6.36,1
675.0,O=C(O)C1CCc2cc(C3CCCCC3)c(Cl)cc21,,O=C(O)C1CCc2cc(C3CCCCC3)c(Cl)cc21,clidanac,,NCGC00538320-01,MODERATE,LOW,4.7,-5.35,1
,O=S(=O)(CC1CS1)c1ccc(Oc2ccccc2)cc1,,O=S(=O)(CC1CS1)c1ccc(Oc2ccccc2)cc1,,SB-3CT,,LOW,INACTIVE,3.01,-4.24,0
1440.0,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,indomethacin,Indomethacin,,MODERATE,LOW,4.25,-5.17,1
4832.0,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,,C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](OCCOCCOCCOCCOCCOCCOCCOC)CC[C@@]3(O)[C@H]1C5,naloxegol,Naloxegol (oxalate),,LOW,INACTIVE,1.73,-4.05,0
2866.0,CC(CSC(=O)c1ccccc1)C(=O)N1CC(Sc2ccccc2)CC1C(=O)O,,C[C@H](CSC(=O)c1ccccc1)C(=O)N1C[C@@H](Sc2ccccc2)C[C@H]1C(=O)O,zofenopril,Zofenopril,,LOW,INACTIVE,3.65,-5.14,0
,CCCCCCCCCCCCCCCC(=O)OCC(O)C1OCC(O)C1O,,CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O,,Sorbitan monohexadecanoate,,LOW,INACTIVE,4.61,-4.34,0
1200.0,Fc1ccc(C(c2ccc(F)cc2)N2CCN(CC=Cc3ccccc3)CC2)cc1,,Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1,flunarizine,Flunarizine,,MODERATE,HIGH,5.31,-5.38,1
,Nc1cc(C(Cl)=C(Cl)Cl)c(S(N)(=O)=O)cc1S(N)(=O)=O,,Nc1cc(C(Cl)=C(Cl)Cl)c(S(N)(=O)=O)cc1S(N)(=O)=O,,Clorsulon,NCGC00182084-01,LOW,INACTIVE,1.23,-3.65,0
1343.0,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,guanfacine,Guanfacine hydrochloride,,LOW,INACTIVE,2.27,-3.25,0
,O=C(O)c1cc(-c2ccc(C=C3SC(=S)N(Cc4ccccc4)C3=O)o2)ccc1Cl,,O=C(O)c1cc(-c2ccc(/C=C3\SC(=S)N(Cc4ccccc4)C3=O)o2)ccc1Cl,,4E2RCat,,HIGH,HIGH,4.83,-4.85,1
302.0,Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21,,Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21,bendamustine,Bendamustine,NCGC00181170-09,LOW,INACTIVE,3.06,-3.76,0
1899.0,NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N,,NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N,nepafenac,Nepafenac,,LOW,INACTIVE,1.53,-4.11,0
,O=C1CC(=O)c2c(Cl)c(Cl)c(Cl)c(Cl)c21,,O=C1CC(=O)c2c(Cl)c(Cl)c(Cl)c(Cl)c21,,TCID,,HIGH,HIGH,3.96,-4.68,1
137.0,C=CCc1ccccc1OCC(O)CNC(C)C,,C=CCc1ccccc1OCC(O)CNC(C)C,alprenolol,Alprenolol|Alprenolol hydrochloride,,LOW,INACTIVE,2.38,-3.1,0
,COC(=O)C1(C)CCC2(C)CCC3(C)C4=CC=C5C(=CC(=O)C(O)=C5C)C4(C)CCC3(C)C2C1,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(O)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,,Pristimerin,,HIGH,HIGH,6.6,-5.64,1
2528.0,O=C1C(CCS(=O)c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1,,O=C1C(CCS(=O)c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1,sulfinpyrazone,SULFINPYRAZONE,,MODERATE,LOW,2.92,-3.1,1
518.0,CC(C(=O)O)c1ccc2c(c1)[nH]c1ccc(Cl)cc12,,CC(C(=O)O)c1ccc2c(c1)[nH]c1ccc(Cl)cc12,carprofen,Carprofen,,LOW,MODERATE,4.09,-4.86,0
,COc1cc(-c2oc3cc(O)cc(O)c3c(=O)c2O)ccc1O,,COc1cc(-c2oc3cc(O)cc(O)c3c(=O)c2O)ccc1O,,ISORHAMNETINE,,MODERATE,HIGH,1.96,-3.33,1
,CCC(C)C(NC(=O)C(C(C)CC)N(C)C(C)=O)C(=O)NC(C(=O)NC(CC(C)C)C(=O)C1(C)CO1)C(C)O,,CC[C@H](C)[C@H](NC(=O)[C@H]([C@@H](C)CC)N(C)C(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1)[C@@H](C)O,,Epoxomicin,,LOW,INACTIVE,2.14,-3.5,0
,COC(=O)C1C(O)C2(O)c3c(OC)cc(OC4OC(C(O)CO)COC4OC)cc3OC2(c2ccc(OC)cc2)C1c1ccccc1,,COC(=O)[C@@H]1[C@@H](c2ccccc2)[C@]2(c3ccc(OC)cc3)Oc3cc(O[C@@H]4O[C@@H]([C@H](O)CO)CO[C@H]4OC)cc(OC)c3[C@]2(O)[C@@H]1O,,Silvestrol,,LOW,INACTIVE,2.26,-4.08,0
1783.0,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,metolazone,Metolazone,NCGC00093985-19,LOW,INACTIVE,3.03,-3.96,0
,CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1,,CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1,,M-344,,LOW,INACTIVE,1.62,-3.26,0
,CC(C)CC(NC(=O)C(Cc1ccccc1)CC(O)C(Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)NC(Cc1ccccc1)C(N)=O,,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,L-685458,,HIGH,HIGH,3.93,-5.99,1
,CCOC(=O)NCCCC(=O)NCCc1ccccc1,,CCOC(=O)NCCCC(=O)NCCc1ccccc1,,Santacruzamate A (CAY10683),,LOW,INACTIVE,1.84,-3.64,0
2446.0,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,sirolimus,Sirolimus,NCGC00021305-08,HIGH,HIGH,4.82,-5.74,1
1325.0,CC1(C(=O)O)CCC2(C)CCC3(C)C(=CC(=O)C4C5(C)CCC(OC6OC(C(=O)O)C(O)C(O)C6OC6OC(C(=O)O)C(O)C(O)C6O)C(C)(C)C5CCC43C)C2C1,,CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C,glycyrrhizic acid,Ammonium Glycyrrhizinate|Glycyrrhizic acid,"NCGC00183128-06, NCGC00183128-03",LOW,INACTIVE,2.79,-4.19,0
,Oc1cc(O)cc(C=Cc2ccc(O)cc2O)c1,,Oc1cc(O)cc(/C=C/c2ccc(O)cc2O)c1,,Oxyresveratrol,,HIGH,HIGH,2.06,-3.38,1
,CC(C)C(=O)OCC1(N=[N+]=[N-])OC(n2ccc(N)nc2=O)C(OC(=O)C(C)C)C1OC(=O)C(C)C,,CC(C)C(=O)OC[C@@]1(N=[N+]=[N-])O[C@@H](n2ccc(N)nc2=O)[C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C,,Balapiravir,,LOW,INACTIVE,2.48,-3.74,0
2841.0,CC1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)C=CC(C)C(C)C,,CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3\C[C@@H](O)CC[C@@H]3C)CCC[C@@]21C,dihydrotachysterol,Dihydrotachysterol,,HIGH,HIGH,7.85,-6.5,1
2286.0,CC(CN1c2ccccc2Sc2ccccc21)N(C)C,,CC(CN1c2ccccc2Sc2ccccc21)N(C)C,promethazine,Promethazine|Promethazine HCl,,MODERATE,HIGH,4.52,-4.07,1
67.0,CC(=O)OC1CC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CCC5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)OC(C)C1O,,CC(=O)O[C@H]1C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)O[C@H](C)[C@H]1O,acetyldigitoxin,Digitoxin 3'''-Acetate,,LOW,INACTIVE,2.87,-4.82,0
2544.0,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C,,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,sunitinib,Sunitinib malate,NCGC00164631-19,HIGH,HIGH,3.24,-4.11,1
2608.0,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,testosterone undecanoate,Testosterone (undecanoate),,LOW,INACTIVE,6.79,-6.79,0
3222.0,CCC(C(=O)OCCN1CCOC(c2ccccc2)C1C)c1ccccc1,,CCC(C(=O)OCCN1CCOC(c2ccccc2)C1C)c1ccccc1,fenbutrazate,Fenbutrazate,,LOW,INACTIVE,4.28,-4.64,0
,CCCCC(=O)OCC(=O)C1C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,,CCCCC(=O)OCC(=O)[C@H]1[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,,Diflucortolone valerate,,MODERATE,LOW,3.95,-4.89,1
1228.0,C[N+]1(CCF)C2CCC1CC(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2,,C[N@@+]1(CCF)[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)(c1ccccc1)c1ccccc1)C2,flutropium,Flutropium bromide,,LOW,INACTIVE,1.84,-6.23,0
3323.0,CCCCCC=CCC=CCCCCCCCC(=O)O,,CCCCC/C=C\C/C=C\CCCCCCCC(=O)O,linoleic acid,"9(E),12(E)-Octadecadienoic acid",,MODERATE,HIGH,7.06,-6.26,1
2588.0,Oc1cccc(-c2c3nc(c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4nc(c(-c5cccc(O)c5)c5ccc2[nH]5)CC4)C=C3)c1,,Oc1cccc(-c2c3nc(c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4nc(c(-c5cccc(O)c5)c5ccc2[nH]5)CC4)C=C3)c1,temoporfin,Temoporfin,,HIGH,HIGH,6.82,-5.24,1
1372.0,Oc1ccc(C(O)CNCCCCCCNCC(O)c2ccc(O)c(O)c2)cc1O,,Oc1ccc(C(O)CNCCCCCCNCC(O)c2ccc(O)c(O)c2)cc1O,hexoprenaline,Hexoprenaline sulfate,,HIGH,HIGH,1.17,-3.33,1
,O=c1c(C2CC(c3ccc(-c4ccc(Br)cc4)cc3)Cc3ccccc32)c(O)sc2ccccc12,,O=c1c(C2CC(c3ccc(-c4ccc(Br)cc4)cc3)Cc3ccccc32)c(O)sc2ccccc12,,Difethialone,,HIGH,HIGH,7.78,-7.21,1
,CC1(C)CC(NC(=O)C(=O)Nc2ccc(Br)cc2)CC(C)(C)N1,,CC1(C)CC(NC(=O)C(=O)Nc2ccc(Br)cc2)CC(C)(C)N1,,NBD-557,,LOW,INACTIVE,2.81,-4.62,0
,CC(=O)Nc1ccc(C(=O)Nc2ccccc2N)cc1,,CC(=O)Nc1ccc(C(=O)Nc2ccccc2N)cc1,,Tacedinaline,NCGC00263639-13,LOW,INACTIVE,1.51,-3.89,0
642.0,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC=Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1,,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1,cilnidipine,Cilnidipine,,MODERATE,HIGH,4.36,-5.95,1
1609.0,CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O,,CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O,lornoxicam,Lornoxicam,NCGC00346667-07,MODERATE,HIGH,3.09,-3.93,1
,O=C(C=Cc1ccc(O)c(O)c1)OC1CC(O)(C(=O)O)CC(O)C1OC(=O)C=Cc1ccc(O)c(O)c1,,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,,Isochlorogenic acid C,,LOW,LOW,2.07,-3.62,0
4749.0,OCCOc1ccc(C(=C(CCCl)c2ccccc2)c2ccccc2)cc1,,OCCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1,ospemifene,Ospemifene,NCGC00386347-02,MODERATE,HIGH,5.78,-5.86,1
4799.0,OCc1cc(C(O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O,,OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O,vilanterol,Vilanterol (GW642444; GW 642444X),,LOW,INACTIVE,3.78,-5.61,0
1359.0,CCCCCCC(COC(=O)c1cccnc1)(COC(=O)c1cccnc1)COC(=O)c1cccnc1,,CCCCCCC(COC(=O)c1cccnc1)(COC(=O)c1cccnc1)COC(=O)c1cccnc1,hepronicate,,NCGC00538142-01,MODERATE,HIGH,3.51,-5.14,1
5077.0,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1,,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1,selexipag,NS-304,,HIGH,HIGH,4.4,-5.06,1
1904.0,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,nevirapine,Nevirapine,,LOW,INACTIVE,1.74,-3.4,0
352.0,CCCC(=O)OC1(C(=O)COC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,,CCCC(=O)O[C@]1(C(=O)COC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,betamethasone butyrate propionate,Betamethasone butyrate propionate,,MODERATE,HIGH,3.92,-5.11,1
333.0,CN1C2CCC1CC(OC(c1ccccc1)c1ccccc1)C2,,CN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2,benzatropine,Benztropine mesylate,,LOW,INACTIVE,4.48,-5.41,0
2648.0,Cc1ccsc1C(=CCCN1CCCC(C(=O)O)C1)c1sccc1C,,Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C,tiagabine,Tiagabine hydrochloride,NCGC00164626-07,LOW,INACTIVE,4.98,-4.26,0
799.0,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,delavirdine,Delavirdine|Delavirdine (mesylate),,MODERATE,LOW,2.77,-3.72,1
,CCC(C)(C)OC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(Cc1ccccc1)C(N)=O,,CCC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,Amogastrin,,MODERATE,HIGH,2.26,-5.66,1
3098.0,CCOC(=O)COc1ccc2c(C)c(CCN(CC)CC)c(=O)oc2c1,,CCOC(=O)COc1ccc2c(C)c(CCN(CC)CC)c(=O)oc2c1,carbocromen,Chromonar hydrochloride,,LOW,INACTIVE,3.55,-3.91,0
,Cc1[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCN1CCCC1,,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCN1CCCC1,,Toceranib,NCGC00378902-02,MODERATE,HIGH,2.82,-4.05,1
,C1CCC(NC2CCCCC2)CC1,,C1CCC(NC2CCCCC2)CC1,,Dicyclohexylamine,,LOW,INACTIVE,4.16,-4.27,0
,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,,Candesartan,,LOW,INACTIVE,4.03,-4.75,0
577.0,COCc1c(C(C)C)nc(C(C)C)c(C=CC(O)CC(O)CC(=O)O)c1-c1ccc(F)cc1,,COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1,cerivastatin,Cerivastatin sodium,,MODERATE,HIGH,4.15,-5.05,1
,c1ccc2c(c1)sc1ccccc12,,c1ccc2c(c1)sc1ccccc12,,Dibenzothiophene,,LOW,INACTIVE,4.38,-4.07,0
2396.0,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,,C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1,rocuronium,Rocuronium bromide,NCGC00167433-06,LOW,INACTIVE,2.71,-7.3,0
680.0,CCC(C)(Oc1ccc(C2(c3ccc(OC(C)(CC)C(=O)O)cc3)CCCCC2)cc1)C(=O)O,,CCC(C)(Oc1ccc(C2(c3ccc(OC(C)(CC)C(=O)O)cc3)CCCCC2)cc1)C(=O)O,clinofibrate,Clinofibrate,NCGC00167453-04,MODERATE,HIGH,5.75,-6.33,1
1685.0,CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCC1=C(C)C(=O)c2ccccc2C1=O,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=C(C)C(=O)c2ccccc2C1=O,menatetrenone,Menaquinone,,HIGH,HIGH,7.24,-5.96,1
1991.0,CC(=C(OCCOc1ccc(Cl)cc1)c1ccc(Cl)cc1Cl)n1ccnc1,,C/C(=C(/OCCOc1ccc(Cl)cc1)c1ccc(Cl)cc1Cl)n1ccnc1,omoconazole,Omoconazole,,HIGH,HIGH,5.86,-5.66,1
989.0,O=C1Nc2ccc(Cl)cc2C(C#CC2CC2)(C(F)(F)F)O1,,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,efavirenz,Efavirenz,NCGC00159337-12,LOW,MODERATE,3.87,-4.57,0
,CC[N+](CC)(CC(=O)Nc1c(C)cccc1C)Cc1ccccc1,,CC[N+](CC)(CC(=O)Nc1c(C)cccc1C)Cc1ccccc1,,Denatonium benzoate,,LOW,INACTIVE,2.4,-6.68,0
1912.0,O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,,O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,niclosamide,Niclosamide,NCGC00015735-18,MODERATE,HIGH,4.49,-4.63,1
,Cn1cc(-c2ccc(S(=O)(=O)n3ccc(C=CC(=O)Nc4ccccc4N)c3)cc2)cn1,,Cn1cc(-c2ccc(S(=O)(=O)n3ccc(/C=C/C(=O)Nc4ccccc4N)c3)cc2)cn1,,4SC-202,,HIGH,HIGH,2.87,-4.21,1
570.0,COc1ccc2c(c1)OC(C)(C)C(c1ccccc1)C2c1ccc(OCCN2CCCC2)cc1,,COc1ccc2c(c1)OC(C)(C)C(c1ccccc1)C2c1ccc(OCCN2CCCC2)cc1,ormeloxifene,Ormeloxifene,,HIGH,HIGH,6.73,-6.65,1
,NC(=O)C(CCC(F)(F)F)N(Cc1ccc(-c2ncon2)cc1F)S(=O)(=O)c1ccc(Cl)cc1,,NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(-c2ncon2)cc1F)S(=O)(=O)c1ccc(Cl)cc1,,Avagacestat,,MODERATE,HIGH,3.17,-4.29,1
1416.0,COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O,,COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O,idebenone,Idebenone,NCGC00160514-14,HIGH,HIGH,3.98,-4.32,1
4912.0,COC(=O)NC(C(=O)N1CCCC1C(=O)Nc1ccc(C2CCC(c3ccc(NC(=O)C4CCCN4C(=O)C(NC(=O)OC)C(C)C)cc3)N2c2ccc(C(C)(C)C)cc2)cc1)C(C)C,,COC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc([C@@H]2CC[C@@H](c3ccc(NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)OC)C(C)C)cc3)N2c2ccc(C(C)(C)C)cc2)cc1)C(C)C,ombitasvir,Ombitasvir|ombitasvir,,HIGH,HIGH,5.73,-5.67,1
1064.0,CCCCC(=O)OC1CCC2C3CCc4cc(O)ccc4C3CCC12C,,CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C,estradiol valerate,Estradiol valerate,,MODERATE,HIGH,5.28,-5.76,1
,O=c1[nH]nc2c3c(cccc13)NC(CN1Cc3ccccc3C1)=N2,,O=c1[nH]nc2nc(CN3Cc4ccccc4C3)[nH]c3cccc1c23,,E-7449,,MODERATE,HIGH,1.75,-3.04,1
1752.0,COc1ccc2c(c1)N(CC(C)CN(C)C)c1ccccc1S2,,COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2,levomepromazine,Methotrimeprazine maleat salt,,MODERATE,HIGH,4.97,-4.8,1
4359.0,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,bosutinib,Bosutinib,NCGC00241107-12,MODERATE,HIGH,4.81,-4.74,1
1043.0,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)CC21,,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21,ergotamine,Ergotamine tartrate,,HIGH,HIGH,2.51,-3.44,1
,CCN(CC)CCOc1ccc2c(c1)C(=O)c1cc(OCCN(CC)CC)ccc1-2,,CCN(CC)CCOc1ccc2c(c1)C(=O)c1cc(OCCN(CC)CC)ccc1-2,,TILORONE,,LOW,INACTIVE,4.64,-3.75,0
4322.0,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,azilsartan medoxomil,Azilsartan Medoxomil,,HIGH,HIGH,4.94,-4.91,1
,CNC(=O)C(NC(=O)C(CCCc1ccccc1)C(C)N(O)C=O)C(C)(C)C,,CNC(=O)[C@@H](NC(=O)[C@H](CCCc1ccccc1)[C@H](C)N(O)C=O)C(C)(C)C,,GI254023X,,LOW,INACTIVE,2.36,-4.32,0
,Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)NC1C(=O)N2C1SC(C)(C)C2C(=O)[O-],,Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12,,Dicloxacillin sodium salt monohydrate,,LOW,INACTIVE,3.19,-4.2,0
1834.0,Oc1ccc(OCc2ccccc2)cc1,,Oc1ccc(OCc2ccccc2)cc1,monobenzone,Monobenzone,,LOW,INACTIVE,3.1,-3.7,0
3548.0,Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2,,Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2,sitaxentan,Sitaxentan,NCGC00253587-02,MODERATE,HIGH,3.35,-4.4,1
,NCCCCN(Cc1nc2ccccc2[nH]1)C1CCCc2cccnc21,,NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21,,AMD-070 (hydrochloride),,MODERATE,HIGH,2.59,-4.09,1
1299.0,Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1,,Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1,gliclazide,Gliclazide,NCGC00095107-18,LOW,INACTIVE,1.49,-3.23,0
4354.0,C=CCC1=C(C)C(OC(=O)C2C(C=C(C)C)C2(C)C)CC1=O,,C=CCC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](C=C(C)C)C2(C)C)CC1=O,bioallethrin,Allethrin,,MODERATE,LOW,3.58,-4.18,1
1699.0,COC1(OC2CCC3C4CCC5CC6SC6CC5(C)C4CCC23C)CCCC1,,COC1(O[C@H]2CC[C@H]3[C@@H]4CC[C@H]5C[C@@H]6S[C@@H]6C[C@]5(C)[C@H]4CC[C@]23C)CCCC1,mepitiostane,"Mepitiostane (Contains ~15% 3a,4a-Epithio isomer)",,LOW,INACTIVE,5.19,-6.96,0
,C=CCc1ccc(O)c(-c2ccc(O)c(CC=C)c2)c1,,C=CCc1ccc(O)c(-c2ccc(O)c(CC=C)c2)c1,,Honokiol,,LOW,INACTIVE,4.7,-4.49,0
59.0,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,acetophenazine,Acetophenazine Maleate,,MODERATE,LOW,3.48,-3.84,1
2550.0,CCOC(=O)Oc1c(OC)cc(C(=O)OC2CC3CN4CCc5c([nH]c6cc(OC)ccc56)C4CC3C(C(=O)OC)C2OC)cc1OC,,CCOC(=O)Oc1c(OC)cc(C(=O)O[C@@H]2C[C@@H]3CN4CCc5c([nH]c6cc(OC)ccc56)[C@H]4C[C@@H]3[C@H](C(=O)OC)[C@H]2OC)cc1OC,syrosingopine,Syrosingopine,,HIGH,HIGH,4.4,-4.84,1
,CC(=O)C1=C(O)C=C2Oc3c(C(C)=O)c(O)c(C)c(O)c3C2(C)C1=O,,CC(=O)C1=C(O)C=C2Oc3c(C(C)=O)c(O)c(C)c(O)c3[C@]2(C)C1=O,,(+)-Usniacin,,MODERATE,HIGH,2.34,-3.09,1
,CC(CN(C)C)CN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,,CC(CN(C)C)CN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,,Trifluomeprazine 2-butenedioate,,MODERATE,HIGH,5.61,-5.54,1
,Cc1cc(-n2c(=O)[nH]c(=O)n(C)c2=O)ccc1Oc1ccc(SC(F)(F)F)cc1,,Cc1cc(-n2c(=O)[nH]c(=O)n(C)c2=O)ccc1Oc1ccc(SC(F)(F)F)cc1,,TOLTRAZURIL,,MODERATE,HIGH,3.59,-5.04,1
,COc1ccc(C(C)(C)C)cc1CNC1C2CCN(CC2)C1C(c1ccccc1)c1ccccc1,,COc1ccc(C(C)(C)C)cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1,,Maropitant,,LOW,INACTIVE,6.27,-6.87,0
1986.0,CN(C)CCC=C1c2ccccc2COc2ccc(CC(=O)O)cc21,,CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21,olopatadine,Olopatadine hydrochloride,NCGC00263532-10,LOW,INACTIVE,3.99,-4.03,0
4716.0,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,ponatinib,Ponatinib,NCGC00263152-15,HIGH,HIGH,3.94,-5.26,1
,CNC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)C(CSc1cccs1)C(=O)NO,,CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)[C@H](CSc1cccs1)C(=O)NO,,Batimastat,,LOW,INACTIVE,3.23,-5.44,0
1996.0,CCCCCCCCCCCC(CC1OC(=O)C1CCCCCC)OC(=O)C(CC(C)C)NC=O,,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,orlistat,Orlistat,NCGC00165856-14,LOW,INACTIVE,7.61,-6.73,0
,COc1ccc(C(=O)C2CCN(CC(=O)N(Cc3nc4c(c(=O)[nH]3)COCC4)CC3CC3)CC2)cc1,,COc1ccc(C(=O)C2CCN(CC(=O)N(Cc3nc4c(c(=O)[nH]3)COCC4)CC3CC3)CC2)cc1,,TNKS-656,,LOW,INACTIVE,2.08,-3.6,0
4289.0,CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)O,,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,doconexent,DOCONEXENT,,LOW,INACTIVE,6.83,-6.25,0
,Cc1cccc2c3c(ccc12)C1=C(C(=O)C3=O)C(C)CO1,,Cc1cccc2c3c(ccc12)C1=C(C(=O)C3=O)[C@@H](C)CO1,,DIHYDROTANSHINONE I,,HIGH,HIGH,3.63,-4.56,1
925.0,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C2NC(COCCOC)OC(C2C)C1(C)O,,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O,dirithromycin,Dirithromycin,,LOW,INACTIVE,2.5,-3.56,0
1610.0,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,losartan,Losartan|Losartan potassium,,MODERATE,HIGH,3.81,-4.96,1
82.0,Cc1ccc(C(=CCN2CCCC2)c2cccc(C=CC(=O)O)n2)cc1,,Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1,acrivastine,Acrivastine,,LOW,INACTIVE,4.29,-4.55,0
880.0,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O,,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O,diflunisal,Diflunisal,,LOW,INACTIVE,3.11,-3.55,0
4153.0,COC1C(=O)C2(C)C(OC)CC3OCC3(OC(C)=O)C2C(OC(=O)c2ccccc2)C2(O)CC(OC(=O)C(O)C(NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C,,CO[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C(C)=C([C@@H](OC)C(=O)[C@]12C)C3(C)C,cabazitaxel,Cabazitaxel,NCGC00346704-07,MODERATE,HIGH,3.69,-5.31,1
,CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(CSC(=O)c3ccco3)CSC12)c1csc(N)n1,,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSC(=O)c3ccco3)CS[C@H]12)c1csc(N)n1,,CEFTIOFUR HYDROCHLORIDE,,MODERATE,HIGH,1.2,-3.7,1
2407.0,CCCN(CCc1cccs1)C1CCc2c(O)cccc2C1,,CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1,rotigotine,Rotigotine,,LOW,MODERATE,5.01,-4.55,0
226.0,O=C1c2c(O)cccc2Cc2cccc(O)c21,,O=C1c2c(O)cccc2Cc2cccc(O)c21,dithranol,Anthralin,,HIGH,HIGH,2.73,-3.09,1
4456.0,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O,,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O,hydrocortisone succinate,Hydrocortisone 21-hemisuccinate sodium salt,,LOW,INACTIVE,2.18,-3.85,0
1001.0,CCC1CN2CCc3cc(OC)c(OC)cc3C2CC1CC1NCCc2cc(OC)c(OC)cc21,,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21,emetine,EMETINE DIHYDROCHLORIDE|Emetine dihydrochloride hydrate|Emetine,NCGC00024379-18,LOW,INACTIVE,4.18,-5.23,0
78.0,COc1cc(C)c(C=CC(C)=CC=CC(C)=CC(=O)O)c(C)c1C,,COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C,acitretin,Acitretin,NCGC00163127-08,HIGH,HIGH,5.24,-5.83,1
,COc1ccc(-c2cc(C(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1F,,COc1ccc(-c2cc(C(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1F,,Deracoxib,,MODERATE,LOW,3.39,-4.58,1
569.0,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1,,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1,celiprolol,Celiprolol hydrochloride,,LOW,INACTIVE,2.14,-3.34,0
1208.0,CC(=O)C1(O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,fluorometholone,Fluorometholone,,LOW,INACTIVE,2.34,-4.36,0
581.0,O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,,O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,cetirizine,CETIRIZINE HYDROCHLORIDE,,LOW,INACTIVE,2.8,-3.77,0
,CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,,CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,,PJ34 Hydrochloride,,LOW,INACTIVE,1.86,-3.55,0
2441.0,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,sildenafil,Sildenafil citrate,,HIGH,HIGH,1.8,-3.01,1
,COC(=O)c1cc(OC)c2c(c1-c1c(CO)cc(OC)c3c1OCO3)OCO2,,COC(=O)c1cc(OC)c2c(c1-c1c(CO)cc(OC)c3c1OCO3)OCO2,,Bicyclol,,LOW,INACTIVE,1.55,-3.16,0
3050.0,CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1,,CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1,butacaine,Butacaine,,LOW,INACTIVE,4.46,-3.86,0
2030.0,COc1cccc(C(=O)CCNC(C)C(O)c2ccccc2)c1,,COc1cccc(C(=O)CCN[C@@H](C)[C@H](O)c2ccccc2)c1,oxyfedrine,l-Oxyfedrine hydrochloride,,LOW,INACTIVE,2.39,-4.16,0
2032.0,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,oxymetazoline,Oxymetazoline hydrochloride,NCGC00015766-16,LOW,INACTIVE,3.7,-3.71,0
1059.0,CC12CCC3c4ccc(O)cc4CCC3C1CCC2OC(=O)CCC1CCCC1,,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1,estradiol cypionate,Estradiol cypionate,,MODERATE,HIGH,6.48,-6.53,1
1086.0,CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21,,CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21,profenamine,Ethopropazine hydrochloride,,MODERATE,HIGH,5.88,-4.78,1
,Nc1[nH]nc2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,,Nc1[nH]nc2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,,FR-180204,NCGC00183912-09,MODERATE,HIGH,3.01,-3.88,1
,[H]C([H])([H])C(O)(CCOC(C)C1CCC2C(=CC=C3CC(O)CC(O)C3=C)CCCC21C)C([H])([H])[H],,[2H]C([2H])([2H])C(O)(CCO[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3/C[C@@H](O)C[C@H](O)C3=C)CCC[C@]12C)C([2H])([2H])[2H],,Maxacalcitol-D6,,LOW,INACTIVE,4.51,-4.46,0
170.0,CC(CC(C(N)=O)(c1ccccc1)c1ccccc1)N(C)C,,CC(CC(C(N)=O)(c1ccccc1)c1ccccc1)N(C)C,dimevamide,Aminopentamide sulfate,,LOW,INACTIVE,2.62,-4.01,0
,CN1C(N)=NC(C)(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)CS1(=O)=O,,CN1C(N)=N[C@](C)(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)CS1(=O)=O,,Verubecestat (MK-8931),,LOW,INACTIVE,1.84,-4.05,0
2366.0,CCOc1cc(CC(=O)NC(CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O,,CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O,repaglinide,Repaglinide,NCGC00016978-13,MODERATE,MODERATE,5.05,-5.19,1
2562.0,CCOc1ccccc1OCCNC(C)Cc1ccc(OC)c(S(N)(=O)=O)c1,,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1,tamsulosin,Tamsulosin hydrochloride,,LOW,INACTIVE,3.06,-4.8,0
,CCS(=O)(=O)Nc1ccc2[nH]c(O)c(C(=Nc3ccc(CN4CCCCC4)cc3)c3ccccc3)c2c1,,CCS(=O)(=O)Nc1ccc2[nH]c(O)c(C(=Nc3ccc(CN4CCCCC4)cc3)c3ccccc3)c2c1,,Hesperadin,,HIGH,HIGH,5.35,-5.63,1
475.0,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,candesartan cilexetil,Candesartan cilexetil (Atacand),,HIGH,MODERATE,5.12,-5.47,1
5058.0,CNc1ncc(-c2ccc3c(=O)c(C(=O)O)cn(C4CC4)c3c2C)cc1C,,CNc1ncc(-c2ccc3c(=O)c(C(=O)O)cn(C4CC4)c3c2C)cc1C,ozenoxacin,OZENOXACIN,,LOW,INACTIVE,2.76,-3.55,0
,O=C(Cc1ccccc1)Nc1nnc(CCSCCc2nnc(NC(=O)Cc3ccccc3)s2)s1,,O=C(Cc1ccccc1)Nc1nnc(CCSCCc2nnc(NC(=O)Cc3ccccc3)s2)s1,,BPTES,,LOW,INACTIVE,3.38,-5.34,0
4654.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,regorafenib,Regorafenib,NCGC00263138-10,HIGH,HIGH,4.53,-5.67,1
,Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1,,Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1,,LMK235,,LOW,INACTIVE,1.5,-3.28,0
,CC(C)(F)CC(NC(c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1,,CC(C)(F)C[C@H](N[C@@H](c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1,,Odanacatib,,LOW,INACTIVE,4.04,-4.9,0
2561.0,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,tamoxifen,Tamoxifen,NCGC00024928-14,HIGH,HIGH,5.93,-5.56,1
2525.0,O=C(O)c1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,,O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,sulfasalazine,Sulfasalazine,NCGC00090903-01,MODERATE,HIGH,2.9,-3.93,1
1110.0,C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3C(=C)CC21CC,,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC,etonogestrel,Etonogestrel,,LOW,INACTIVE,3.19,-4.64,0
4151.0,CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F,,C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F,silodosin,Silodosin,,LOW,INACTIVE,2.95,-4.66,0
1282.0,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,gefitinib,Gefitinib,NCGC00159455-27,LOW,INACTIVE,4.02,-4.22,0
1911.0,O=C(OCC(COC(=O)c1cccnc1)(COC(=O)c1cccnc1)COC(=O)c1cccnc1)c1cccnc1,,O=C(OCC(COC(=O)c1cccnc1)(COC(=O)c1cccnc1)COC(=O)c1cccnc1)c1cccnc1,niceritrol,Niceritrol,,LOW,INACTIVE,1.88,-4.69,0
4606.0,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1C(=O)COC(=O)C(C)(C)C,,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C,clocortolone pivalate,Clocortolone pivalate,,LOW,INACTIVE,4.14,-5.68,0
,CCC(=C(CC)c1ccc(OP(=O)([O-])[O-])cc1)c1ccc(OP(=O)([O-])[O-])cc1,,CC/C(=C(/CC)c1ccc(OP(=O)([O-])[O-])cc1)c1ccc(OP(=O)([O-])[O-])cc1,,Fosfestrol tetrasodium,,LOW,INACTIVE,2.86,-4.31,0
,COC(=O)c1cc(Cl)ccc1NS(=O)(=O)C(F)(F)F,,COC(=O)c1cc(Cl)ccc1NS(=O)(=O)C(F)(F)F,,Amidoflumet,,LOW,INACTIVE,3.76,-3.86,0
3483.0,CCC(C(C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O,,CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O,posaconazole,Posaconazole,NCGC00185736-03,HIGH,HIGH,4.71,-4.77,1
2339.0,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21,,CCCN1C[C@@H](NS(=O)(=O)N(CC)CC)C[C@@H]2Cc3c(O)cccc3C[C@H]21,quinagolide,Quinagolide (hydrochloride),,LOW,INACTIVE,2.56,-3.41,0
,O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2)nc1)NO,,O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2)nc1)NO,,ACY-1215,NCGC00345802-09,LOW,INACTIVE,3.04,-4.49,0
3395.0,CCCCC(CC)COC(=O)C(C#N)=C(c1ccccc1)c1ccccc1,,CCCCC(CC)COC(=O)C(C#N)=C(c1ccccc1)c1ccccc1,octocrylene,Octocrylene,NCGC00091585-03,HIGH,HIGH,6.23,-5.36,1
1615.0,CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1,,CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1,loxoprofen,LOXOPROFEN SODIUM,,LOW,INACTIVE,2.94,-3.57,0
,CNC(=O)c1cc(Oc2ccc3nc(NC4CCCCC4O)sc3c2)ccn1,,CNC(=O)c1cc(Oc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)ccn1,,BLZ945,NCGC00386432-02,LOW,INACTIVE,3.37,-4.78,0
,C=CC(=O)N1CC(=Cc2ccc([N+](=O)[O-])cc2)C(=O)C(=Cc2ccc([N+](=O)[O-])cc2)C1,,C=CC(=O)N1C/C(=C\c2ccc([N+](=O)[O-])cc2)C(=O)/C(=C/c2ccc([N+](=O)[O-])cc2)C1,,b-AP15,,HIGH,HIGH,3.39,-5.38,1
,CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(C(=O)NS(=O)(=O)C2CC2)NC(=O)C2CC(OC(=O)N3Cc4cccc(F)c4C3)CN2C1=O,,CC(C)(C)OC(=O)N[C@H]1CCCCCC=C[C@@H]2C[C@@]2(C(=O)NS(=O)(=O)C2CC2)NC(=O)[C@@H]2C[C@@H](OC(=O)N3Cc4cccc(F)c4C3)CN2C1=O,,Danoprevir,NCGC00346498-01,LOW,MODERATE,2.37,-4.29,0
2207.0,CC1CCCC(C)N1CCCC(O)(c1ccccc1)c1ccccn1,,C[C@H]1CCC[C@@H](C)N1CCCC(O)(c1ccccc1)c1ccccn1,pirmenol,Pirmenol,,LOW,INACTIVE,4.27,-3.9,0
,O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12,,O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12,,Baicalein,,HIGH,HIGH,3.19,-3.25,1
2968.0,CC(C)CC(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1c[nH]cn1)NC(=O)C1CCC(=O)N1)C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NCC(N)=O,,CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,triptorelin,Triptorelin,,MODERATE,HIGH,1.07,-4.63,1
1142.0,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,felodipine,Felodipine,,MODERATE,HIGH,4.22,-4.73,1
1522.0,CC(=O)CCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O,,CC(=O)CCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O,kebuzone,Kebuzone,,MODERATE,LOW,1.98,-3.45,1
4152.0,CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1,,CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1,permethrin,PERMETHRIN,,MODERATE,HIGH,6.24,-6.75,1
,O=[N+]([O-])c1ccc(Oc2ccc(N=C=S)cc2)cc1,,O=[N+]([O-])c1ccc(Oc2ccc(N=C=S)cc2)cc1,,Nitroscanate,,HIGH,HIGH,4.78,-4.62,1
353.0,CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,betamethasone dipropionate,"BETAMETHASONE 17,21-DIPROPIONATE",NCGC00159360-03,LOW,MODERATE,3.38,-5.04,0
2243.0,CCOC(=O)OC1(C(=O)COC(=O)CC)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,,CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,prednicarbate,PREDNICARBATE,,MODERATE,HIGH,3.08,-4.94,1
2760.0,NS(=O)(=O)c1cc(C(=O)NN2CC3C4CCC(C4)C3C2)ccc1Cl,,NS(=O)(=O)c1cc(C(=O)NN2C[C@H]3[C@H]4CC[C@H](C4)[C@H]3C2)ccc1Cl,tripamide,Tripamide,,LOW,INACTIVE,1.89,-3.57,0
5215.0,COc1ccc2c(c1)C1CC1(C(=O)N1C3CCC1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)N(C)C)cc21,,COc1ccc2c(c1)[C@@H]1C[C@]1(C(=O)N1C3CCC1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)N(C)C)cc21,beclabuvir,BMS-791325 hydrochloride,,HIGH,HIGH,4.47,-5.19,1
2603.0,CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C,,CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C,terodiline,Terodiline hydrochloride,,LOW,INACTIVE,5.44,-5.95,0
,CCCC(NC1CCc2cc(F)cc(F)c2C1)C(=O)Nc1cn(C(C)(C)CNCC(C)(C)C)cn1,,CCC[C@H](N[C@H]1CCc2cc(F)cc(F)c2C1)C(=O)Nc1cn(C(C)(C)CNCC(C)(C)C)cn1,,Nirogacestat,NCGC00378713-03,MODERATE,LOW,3.92,-4.67,1
,Cc1ccc(NC(=O)C(=O)NC2CC(C)(C)NC(C)(C)C2)cc1,,Cc1ccc(NC(=O)C(=O)NC2CC(C)(C)NC(C)(C)C2)cc1,,YYA-021,,LOW,INACTIVE,2.07,-4.01,0
2361.0,CCOc1ccccc1OC(c1ccccc1)C1CNCCO1,,CCOc1ccccc1O[C@H](c1ccccc1)[C@H]1CNCCO1,reboxetine,Reboxetine mesylate,,LOW,INACTIVE,3.06,-4.15,0
2823.0,CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C)C3C(O)(C(=O)OC)C(OC(C)=O)C5(CC)C=CCN6CCC43C65)C2)C1,,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,vinblastine,Vinblastine sulfate,NCGC00263548-23,HIGH,HIGH,4.22,-4.72,1
1973.0,COc1ccc2c(c1OC)C(=O)OC2C1c2c(cc3c(c2OC)OCO3)CCN1C,,COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C,noscapine,Noscapine,NCGC00023230-28,LOW,INACTIVE,2.0,-3.36,0
3064.0,COc1cc(CNC(=O)CCCCC=CC(C)C)ccc1O,,COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O,capsaicin,(E)-Capsaicin|(Z)-Capsaicin,NCGC00017337-22,LOW,INACTIVE,3.8,-4.56,0
2355.0,CCC(=O)NCCC1CCc2ccc3c(c21)CCO3,,CCC(=O)NCC[C@@H]1CCc2ccc3c(c21)CCO3,ramelteon,RAMELTEON,NCGC00095187-09,LOW,INACTIVE,3.03,-4.2,0
2248.0,CC(C)=CCCC(C)=CCCC(C)=CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,,CC(C)=CCC/C(C)=C/CC/C(C)=C/C(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,prednisolone farnesylate,Prednisolone farnesylate,,MODERATE,HIGH,5.66,-5.64,1
2799.0,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,valdecoxib,Valdecoxib,NCGC00095129-15,LOW,INACTIVE,3.32,-3.95,0
687.0,NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccc(Cl)cc32)CC1,,NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccc(Cl)cc32)CC1,clocapramine,Clocapramine,,MODERATE,HIGH,5.14,-4.75,1
2340.0,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2ccccc2CC1C(=O)O,,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O,quinapril,Quinapril hydrochloride,,LOW,INACTIVE,1.38,-4.71,0
761.0,NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O,,NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O,cyclothiazide,Cyclothiazide,,LOW,INACTIVE,1.32,-3.15,0
2253.0,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,prednisone,Prednisone,NCGC00090766-15,LOW,INACTIVE,2.07,-3.51,0
4548.0,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,flumetasone,Flumethasone,,LOW,MODERATE,1.91,-3.7,0
1532.0,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1C=CC(=O)OC(C)(C)C,,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C,lacidipine,Lacidipine,,HIGH,HIGH,4.69,-5.31,1
4830.0,OCC1OC(c2ccc(Cl)c(Cc3ccc(OC4CCOC4)cc3)c2)C(O)C(O)C1O,,OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,empagliflozin,Empagliflozin (BI 10773),,LOW,INACTIVE,1.79,-3.61,0
4174.0,Cc1cc(C=CC#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,,Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,rilpivirine,Rilpivirine,,HIGH,HIGH,3.8,-4.5,1
5269.0,Cc1ccc(C(=O)OCc2ccc(C(CN)C(=O)Nc3ccc4cnccc4c3)cc2)c(C)c1,,Cc1ccc(C(=O)OCc2ccc([C@@H](CN)C(=O)Nc3ccc4cnccc4c3)cc2)c(C)c1,netarsudil,Netarsudil,,HIGH,HIGH,3.77,-6.21,1
,Clc1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,,Clc1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,,N-Desmethylclozapine,,LOW,MODERATE,3.12,-3.19,0
1169.0,CC(C)=CCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O,,CC(C)=CCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O,feprazone,Feprazone,,LOW,INACTIVE,2.8,-3.48,0
1423.0,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,imatinib,Imatinib,"NCGC00159456-12, NCGC00159456-30",MODERATE,HIGH,3.48,-4.53,1
4868.0,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,umifenovir,Arbidol,NCGC00246387-08,HIGH,HIGH,4.97,-4.85,1
681.0,Oc1c(I)cc(Cl)c2cccnc12,,Oc1c(I)cc(Cl)c2cccnc12,clioquinol,Clioquinol,,HIGH,HIGH,3.67,-3.06,1
,Cc1cc(C(=O)CN2CCCC2)c(C)n1-c1ccc(F)cc1,,Cc1cc(C(=O)CN2CCCC2)c(C)n1-c1ccc(F)cc1,,IU1,,HIGH,HIGH,3.25,-3.43,1
,O=C(C1CCCCC1)N1CC(=O)N2CCCc3ccccc3C2C1,,O=C(C1CCCCC1)N1CC(=O)N2CCCc3ccccc3C2C1,,Epsiprantel,,LOW,INACTIVE,2.68,-3.18,0
2280.0,CCCN(CCC)C(=O)C(CCC(=O)OCCCN1CCN(CCOC(=O)Cc2c(C)n(C(=O)c3ccc(Cl)cc3)c3ccc(OC)cc23)CC1)NC(=O)c1ccccc1,,CCCN(CCC)C(=O)C(CCC(=O)OCCCN1CCN(CCOC(=O)Cc2c(C)n(C(=O)c3ccc(Cl)cc3)c3ccc(OC)cc23)CC1)NC(=O)c1ccccc1,proglumetacin,Proglumetacin,,HIGH,HIGH,5.91,-5.86,1
1097.0,CCCN(CC)C(CC)C(=O)Nc1c(C)cccc1C,,CCCN(CC)C(CC)C(=O)Nc1c(C)cccc1C,etidocaine,Etidocaine,,LOW,INACTIVE,3.05,-3.16,0
,CCCCCCCCCCOc1cc2c(=O)c(C(=O)OCC)c[nH]c2cc1OCC,,CCCCCCCCCCOc1cc2c(=O)c(C(=O)OCC)c[nH]c2cc1OCC,,Decoquinate,,LOW,INACTIVE,6.01,-5.79,0
4618.0,CCC=CCC=CCC=CCCCCCCCC(=O)O,,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O,linolenic acid,Linolenic acid,,MODERATE,LOW,6.62,-6.02,1
2825.0,CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C=O)C3C(O)(C(=O)OC)C(OC(C)=O)C5(CC)C=CCN6CCC43C65)C2)C1,,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,vincristine,Vincristine sulfate,NCGC00163700-14,MODERATE,HIGH,3.36,-4.47,1
2696.0,CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1,,CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1,tolbutamide,Tolbutamide,,LOW,INACTIVE,2.05,-3.13,0
2266.0,COc1cc(NC(C)CCCN)c2ncccc2c1,,COc1cc(NC(C)CCCN)c2ncccc2c1,primaquine,Primaquine diphosphate,,HIGH,HIGH,2.76,-3.67,1
4651.0,CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC,,CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC,dimyristoylphosphatidylcholine,"1,2-Ditetradecanoyl-rac-glycerol-3-phosphocholine",,LOW,INACTIVE,4.43,-7.19,0
3293.0,CC(C)Cc1ccc(CC(=O)O)cc1,,CC(C)Cc1ccc(CC(=O)O)cc1,ibufenac,Ibufenac,,LOW,INACTIVE,3.22,-3.47,0
,CCOC1OC(=O)CC1NC(=O)C1CCCN1C(=O)C(NC(=O)c1ccc(N)c(Cl)c1)C(C)(C)C,,CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1ccc(N)c(Cl)c1)C(C)(C)C,,VX-765,NCGC00183682-14,MODERATE,LOW,2.04,-3.97,1
5142.0,CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1,,CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1,pimavanserin,Pimavanserin,,LOW,INACTIVE,4.18,-4.76,0
726.0,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2,,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,colchicine,Colchicine,NCGC00025125-23,LOW,INACTIVE,1.59,-4.16,0
3439.0,O=S1(=O)OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21,,O=S1(=O)OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21,phenolsulfonphthalein,Phenol red,,LOW,INACTIVE,3.15,-4.29,0
150.0,CC(=O)OCC(=O)C12OC3(CCCC3)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC12C,,CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,amcinonide,AMCINONIDE,,HIGH,HIGH,3.16,-4.81,1
871.0,CC12CCC3=C4CCC(=O)C=C4CCC3C1CCC2(O)CC#N,,C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N,dienogest,Dienogest,NCGC00346502-06,LOW,INACTIVE,3.38,-3.61,0
671.0,CN1CCCC1CCOC(C)(c1ccccc1)c1ccc(Cl)cc1,,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1,clemastine,Clemastine fumarate,,LOW,INACTIVE,5.32,-5.93,0
,NCCS[As](SCCN)c1ccc(Nc2nc(N)nc(N)n2)cc1,,NCCS[As](SCCN)c1ccc(Nc2nc(N)nc(N)n2)cc1,,,NCGC00261972-01,LOW,INACTIVE,1.51,-3.36,0
,CN1N=C2CCN(C(=O)C(COCc3ccccc3)NC(=O)C(C)(C)N)CC2(Cc2ccccc2)C1=O,,CN1N=C2CCN(C(=O)[C@@H](COCc3ccccc3)NC(=O)C(C)(C)N)C[C@@]2(Cc2ccccc2)C1=O,,Capromorelin,,LOW,INACTIVE,1.58,-4.4,0
5256.0,COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21,,COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21,copanlisib,Copanlisib,NCGC00346457-03,LOW,INACTIVE,1.0,-3.32,0
2639.0,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,,CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,thiothixene,THIOTHIXENE,,MODERATE,HIGH,4.01,-4.5,1
2435.0,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,sertindole,Sertindole,,HIGH,HIGH,4.3,-4.66,1
,S=C(NCCc1ccccn1)Nc1ccc(Br)cn1,,S=C(NCCc1ccccn1)Nc1ccc(Br)cn1,,Trovirdine,,LOW,INACTIVE,2.85,-4.81,0
,O=C(CCCCCCCCC#CI)Oc1ccccc1,,O=C(CCCCCCCCC#CI)Oc1ccccc1,,Phenyl 11-iodo-10-undecynoate,,MODERATE,LOW,5.67,-5.46,1
2652.0,CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1,,CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1,tiaprofenic acid,Tiaprofenic acid,,LOW,INACTIVE,3.21,-3.91,0
,O=C(C=Cc1ccc(O)c(O)c1)OC1CC(O)(C(=O)O)CC(OC(=O)C=Cc2ccc(O)c(O)c2)C1O,,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1CC(O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1O,,Isochlorogenic acid A,,MODERATE,HIGH,2.07,-3.62,1
,CN(C)CC=CC(=O)Nc1cccc(C(OCCN2CCCCC2)c2cc3nccc(C(=O)O)c3s2)c1,,CN(C)C/C=C/C(=O)Nc1cccc(C(OCCN2CCCCC2)c2cc3nccc(C(=O)O)c3s2)c1,,,NCGC00490649-01,LOW,INACTIVE,4.17,-5.42,0
5052.0,CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,,CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,aripiprazole lauroxil,ARIPIPRAZOLE LAUROXIL,,MODERATE,MODERATE,7.91,-6.45,1
,Cc1nnc2n1-c1sc(CCC(=O)N3CCOCC3)cc1C(c1ccccc1Cl)=NC2,,Cc1nnc2n1-c1sc(CCC(=O)N3CCOCC3)cc1C(c1ccccc1Cl)=NC2,,Apafant,,MODERATE,HIGH,3.01,-4.06,1
1113.0,Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1,,Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1,etoricoxib,Etoricoxib,NCGC00164578-06,LOW,INACTIVE,3.7,-5.04,0
2305.0,CNC(C)CC1CCCCC1,,CNC(C)CC1CCCCC1,propylhexedrine,Propylhexedrine (hydrochloride),,LOW,INACTIVE,3.37,-3.24,0
776.0,CCCCCCOC(=O)NC(=N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1,,CCCCCCOC(=O)NC(=N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1,dabigatran etexilate,BIBR-1048,NCGC00262929-03,MODERATE,HIGH,5.19,-4.68,1
1508.0,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,,CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1,isotretinoin,Isotretinoin,"NCGC00094358-38, NCGC00017280-37",LOW,INACTIVE,5.66,-4.8,0
272.0,CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1,,CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1,azelnidipine,Azelnidipine,,HIGH,HIGH,5.12,-5.86,1
427.0,CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1,,CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1,bumetanide,Bumetanide,NCGC00015149-25,LOW,INACTIVE,3.22,-4.15,0
,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,,Kaempferol,NCGC00016480-20,MODERATE,HIGH,1.99,-3.21,1
1631.0,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1,,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1,manidipine,Manidipine,,HIGH,HIGH,5.11,-5.8,1
1052.0,CCC(=O)OC1C(OC2C(C)C(OC3CC(C)(OC)C(O)C(C)O3)C(C)C(=O)OC(CC)C(C)(O)C(O)C(C)C(=O)C(C)CC2(C)O)OC(C)CC1N(C)C,,CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,erythromycin propionate,Erythromycin propionate,,LOW,INACTIVE,3.23,-3.63,0
,CCCCN(CCCC)C(=S)[S-],,CCCCN(CCCC)C(=S)[S-],,Zinc dibutyldithiocarbamate,,LOW,HIGH,4.73,-4.16,0
,N#CC(=C(N)Sc1ccccc1N)C(C#N)=C(N)Sc1ccccc1N,,N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N,,U-0126,,MODERATE,HIGH,2.26,-4.06,1
1058.0,CC12CCC3c4ccc(OC(=O)c5ccccc5)cc4CCC3C1CCC2O,,C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,estradiol benzoate,ESTRADIOL BENZOATE,,MODERATE,LOW,5.25,-6.3,1
4690.0,Cc1cc(CCCOc2c(C)cc(-c3noc(C(F)(F)F)n3)cc2C)on1,,Cc1cc(CCCOc2c(C)cc(-c3noc(C(F)(F)F)n3)cc2C)on1,pleconaril,Pleconaril,,LOW,INACTIVE,4.73,-4.24,0
,CCCC(C(=O)O)c1c(C)nc2ccc(Cl)cc2c1-c1ccccc1,,CCCC(C(=O)O)c1c(C)nc2ccc(Cl)cc2c1-c1ccccc1,,HIV-1 integrase inhibitor 2,,LOW,INACTIVE,5.48,-6.0,0
318.0,CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,,CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,benzbromarone,Benzbromarone,,HIGH,HIGH,5.54,-4.51,1
2599.0,CC(C)N1CCN(c2ccc(OCC3COC(Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,,CC(C)N1CCN(c2ccc(OCC3COC(Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,terconazole,Terconazole,,MODERATE,HIGH,4.59,-4.66,1
,Cc1ccc2nc(N)[nH]c(=O)c2c1Sc1ccncc1,,Cc1ccc2nc(N)[nH]c(=O)c2c1Sc1ccncc1,,NOLATREXED HCL,,LOW,INACTIVE,1.9,-3.77,0
,COc1cc(O)c(CC=C(C)C)c2c1C(=O)CC(c1ccc(O)cc1)O2,,COc1cc(O)c(CC=C(C)C)c2c1C(=O)CC(c1ccc(O)cc1)O2,,Isoxanthohumol,,MODERATE,HIGH,3.25,-4.4,1
899.0,COc1ccc2c(=O)c(C)c(-c3ccccc3)oc2c1CN(C)C,,COc1ccc2c(=O)c(C)c(-c3ccccc3)oc2c1CN(C)C,dimefline,Dimefline hydrochloride,,LOW,INACTIVE,3.51,-3.94,0
1592.0,CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1,,CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1,lofepramine,Lofepramine hydrochloride,,MODERATE,HIGH,5.79,-5.7,1
2596.0,CC(=O)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,,CC(=O)CCC=C(C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C,teprenone,Teprenone,,MODERATE,LOW,6.98,-5.31,1
,CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)C(NC(=O)CNCc1cccc(F)c1)C(C)(C)C)S(=O)(=O)c1cccc(N)c1,,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNCc1cccc(F)c1)C(C)(C)C)S(=O)(=O)c1cccc(N)c1,,DPC-681,,MODERATE,HIGH,3.43,-5.32,1
2383.0,CC(N)C12CC3CC(CC(C3)C1)C2,,CC(N)C12CC3CC(CC(C3)C1)C2,rimantadine,Rimantadine,NCGC00159491-08,MODERATE,LOW,3.28,-4.29,1
2152.0,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,phenytoin,"5,5-Diphenylhydantoin",,LOW,INACTIVE,2.26,-3.55,0
1764.0,CCC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,methylergometrine,Methergine,,MODERATE,LOW,1.74,-3.22,1
2745.0,OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1,,OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1,trihexyphenidyl,Trihexyphenidyl hydrochloride,,LOW,INACTIVE,4.93,-4.98,0
,O=c1ccc2cc3ccoc3cc2o1,,O=c1ccc2cc3ccoc3cc2o1,,Psoralen,,LOW,INACTIVE,2.15,-3.14,0
,O=C(Cc1ccccc1)Nc1nnc(NC2CCN(c3nnc(NC(=O)Cc4ccccc4)s3)CC2)s1,,O=C(Cc1ccccc1)Nc1nnc(NC2CCN(c3nnc(NC(=O)Cc4ccccc4)s3)CC2)s1,,UPGL00004,,HIGH,HIGH,3.26,-4.71,1
2405.0,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,rosiglitazone,Rosiglitazone,NCGC00095124-31,LOW,INACTIVE,2.95,-3.97,0
,COc1ccc(-c2oc3cc(O)cc(O)c3c(=O)c2O)cc1,,COc1ccc(-c2oc3cc(O)cc(O)c3c(=O)c2O)cc1,,Kaempferide,,MODERATE,HIGH,2.47,-3.6,1
,CCN1CC(C)n2c(c(O)c3c(=O)n(Cc4ccc(F)c(Cl)c4)nc(C(=O)NC)c32)C1=O,,CCN1C[C@H](C)n2c(c(O)c3c(=O)n(Cc4ccc(F)c(Cl)c4)nc(C(=O)NC)c32)C1=O,,MK-2048,,HIGH,HIGH,2.2,-3.48,1
3557.0,S=C1SCN(Cc2ccccc2)CN1Cc1ccccc1,,S=C1SCN(Cc2ccccc2)CN1Cc1ccccc1,sulbentine,Sulbentine,,LOW,INACTIVE,3.4,-4.63,0
328.0,O=C(OOC(=O)c1ccccc1)c1ccccc1,,O=C(OOC(=O)c1ccccc1)c1ccccc1,benzoyl peroxide,Benzoyl peroxide,,LOW,INACTIVE,2.74,-3.92,0
,COc1ccc(-n2nc(CCC(=O)N(C)O)cc2-c2ccc(Cl)cc2)cc1,,COc1ccc(-n2nc(CCC(=O)N(C)O)cc2-c2ccc(Cl)cc2)cc1,,Tepoxalin,,HIGH,HIGH,4.0,-5.01,1
1922.0,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],nifedipine,Nifedipine,,HIGH,HIGH,2.32,-4.29,1
625.0,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,chlortalidone,Chlorthalidone,,LOW,INACTIVE,1.26,-3.81,0
2545.0,CCOCC(O)COc1ccc(NC(=O)CC[S+](C)C)cc1,,CCOCC(O)COc1ccc(NC(=O)CC[S+](C)C)cc1,suplatast,Suplatast tosylate,NCGC00181000-08,LOW,INACTIVE,2.7,-4.14,0
4685.0,FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,,FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,perflenapent,Perflenapent,,LOW,INACTIVE,3.28,-3.9,0
760.0,CC=CCC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,ciclosporin,Cyclosporine A|Cyclosporin A,NCGC00093704-19,MODERATE,LOW,4.12,-5.09,1
4381.0,CN(C)C(CCOc1cccc2ccccc12)c1ccccc1,,CN(C)[C@@H](CCOc1cccc2ccccc12)c1ccccc1,dapoxetine,Dapoxetine,,LOW,INACTIVE,4.77,-5.56,0
1530.0,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1,,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1,ketotifen,Ketotifen,NCGC00015580-22,LOW,INACTIVE,3.49,-4.59,0
,CN(C)C(=O)Nc1cccc(-c2ccc(N(C)C)cc2)c1,,CN(C)C(=O)Nc1cccc(-c2ccc(N(C)C)cc2)c1,,Atglistatin,,HIGH,HIGH,3.25,-3.57,1
766.0,CC(=O)OC1(C(C)=O)CCC2C3C=C(Cl)C4=CC(=O)C5CC5C4(C)C3CCC21C,,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C,cyproterone acetate,Cyproterone acetate,NCGC00091032-09,MODERATE,HIGH,3.81,-5.44,1
1213.0,CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,,CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,fluphenazine decanoate,Fluphenazine decanoate dihydrochloride,,HIGH,HIGH,7.24,-6.38,1
,CCCCCCCCCCCCCCCCn1cc[n+](Cc2ccccc2)c1C,,CCCCCCCCCCCCCCCCn1cc[n+](Cc2ccccc2)c1C,,NH125,,HIGH,HIGH,4.94,-6.09,1
1349.0,CCC(=O)OC1(C(=O)CCl)C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,ulobetasol propionate,Halobetasol Propionate,,MODERATE,MODERATE,3.81,-4.81,1
,c1ccc2sc(SNC3CCCCC3)nc2c1,,c1ccc2sc(SNC3CCCCC3)nc2c1,,N-Cyclohexyl-2-benzothiazolesulfenamide,,MODERATE,LOW,3.97,-4.31,1
43.0,O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,,O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,aceclofenac,Aceclofenac,,MODERATE,LOW,4.84,-5.25,1
493.0,CC1(C(=O)O)CCC2(C)CCC3(C)C(=CC(=O)C4C5(C)CCC(OC(=O)CCC(=O)O)C(C)(C)C5CCC43C)C2C1,,CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C,carbenoxolone,Carbenoxolone sodium,,MODERATE,HIGH,5.46,-5.92,1
717.0,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,clotiapine,Clothiapine,,MODERATE,LOW,4.11,-4.38,1
472.0,CCN(CC)CCNC(C(=O)OCCC(C)C)c1ccccc1,,CCN(CC)CCNC(C(=O)OCCC(C)C)c1ccccc1,camylofin,Camylofin,,LOW,INACTIVE,3.44,-3.68,0
2413.0,Cc1cncc(CN2CCC(=C3c4ccc(Cl)cc4CCc4cccnc43)CC2)c1,,Cc1cncc(CN2CCC(=C3c4ccc(Cl)cc4CCc4cccnc43)CC2)c1,rupatadine,Rupatadine (Fumarate),,MODERATE,HIGH,4.82,-4.88,1
,CC(C)CC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1,,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,,MG-132,NCGC00161679-02,LOW,INACTIVE,2.95,-4.94,0
,CCCCCCCCCCCCCCCC(=O)OCC(O)C1OC(=O)C(O)=C1O,,CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O,,L-Ascorbyl 6-palmitate,,MODERATE,HIGH,5.23,-4.85,1
1409.0,CC(C)Cc1ccc(C(C)C(=O)OCc2ccccn2)cc1,,CC(C)Cc1ccc(C(C)C(=O)OCc2ccccn2)cc1,ibuprofen piconol,Ibuprofen piconol,,LOW,INACTIVE,4.68,-4.92,0
,O=C(C=Cc1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO,,O=C(/C=C/c1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO,,Dacinostat,NCGC00345539-10,MODERATE,HIGH,2.86,-4.87,1
,NC1CC1c1ccc(-c2cccc(O)c2)cc1,,N[C@H]1C[C@H]1c1ccc(-c2cccc(O)c2)cc1,,,,MODERATE,LOW,2.66,-3.9,1
3135.0,CC1(C)OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,desonide,Desonide,NCGC00274065-06,LOW,INACTIVE,2.32,-3.85,0
,C=CCC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C=CC21C,,C=CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,,Altrenogest,,MODERATE,HIGH,3.74,-4.01,1
,CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1,,CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1,,PHA-680632,,MODERATE,LOW,3.46,-4.1,1
,COc1ccc2cc1Oc1ccc(cc1)CC1c3cc(c(OC)cc3CCN1C)Oc1c(OC)c(OC)cc3c1C(C2)N(C)CC3,,COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3cc(c(OC)cc3CCN1C)Oc1c(OC)c(OC)cc3c1[C@H](C2)N(C)CC3,,Tetrandrine,,MODERATE,HIGH,5.59,-5.32,1
,CCCCCC1Nc2cc(C(F)(F)F)c(S(N)(=O)=O)cc2S(=O)(=O)N1,,CCCCCC1Nc2cc(C(F)(F)F)c(S(N)(=O)=O)cc2S(=O)(=O)N1,,Penflutizide,,LOW,INACTIVE,1.89,-3.14,0
5059.0,CCCCCCOC(C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(C=C(C)C(=O)O)c(Cl)c3)n2)c1OC,,CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC,lusutrombopag,Lusutrombopag,,HIGH,HIGH,6.93,-6.62,1
,CCNC1(c2cccs2)CCCCC1=O,,CCNC1(c2cccs2)CCCCC1=O,,Tiletamine Hydrochloride,,LOW,INACTIVE,2.58,-3.36,0
,CC(C(O)c1ccccc1)N(C)CC=Cc1ccccc1,,CC(C(O)c1ccccc1)N(C)C/C=C/c1ccccc1,,Cinnamedrine,,LOW,INACTIVE,3.72,-3.82,0
2719.0,CCOc1cc(OCC)c(C(=O)CCC(=O)O)cc1OCC,,CCOc1cc(OCC)c(C(=O)CCC(=O)O)cc1OCC,trepibutone,Trepibutone,,LOW,INACTIVE,2.52,-3.48,0
2687.0,Cc1ccc(C(C)OC(=O)C2(C)CCC(C(=O)O)C2(C)C)cc1,,Cc1ccc(C(C)OC(=O)C2(C)CCC(C(=O)O)C2(C)C)cc1,tocamphyl,Tocanfil,,LOW,MODERATE,3.8,-4.42,0
,CCCCCCOc1ccc(C(=N)N(CCCC)CCCC)c2ccccc12,,CCCCCCOc1ccc(C(=N)N(CCCC)CCCC)c2ccccc12,,Bunamidine hydrochloride,,LOW,MODERATE,7.03,-6.62,0
,CCCCCCCCCC(=O)O,,CCCCCCCCCC(=O)O,,Decanoic acid,,LOW,INACTIVE,3.93,-3.26,0
4882.0,CCn1c(=O)c2c(nc(C=Cc3ccc(OC)c(OC)c3)n2C)n(CC)c1=O,,CCn1c(=O)c2c(nc(/C=C/c3ccc(OC)c(OC)c3)n2C)n(CC)c1=O,istradefylline,Istradefylline,NCGC00253737-09,MODERATE,HIGH,2.82,-3.33,1
,O=C([O-])COc1nn(Cc2ccccc2)c2ccccc12,,O=C([O-])COc1nn(Cc2ccccc2)c2ccccc12,,Bendazac sodium,,LOW,INACTIVE,2.89,-3.44,0
1255.0,CC12CCC3c4ccc(O)cc4CC(CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)C3C1CCC2O,,C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O,fulvestrant,Fulvestrant,NCGC00164789-05,MODERATE,HIGH,6.54,-4.99,1
780.0,O=C1CN(N=Cc2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1,,O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1,dantrolene,Dantrolene sodium,,MODERATE,HIGH,1.62,-3.59,1
392.0,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO,,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO,bosentan,Bosentan,,MODERATE,HIGH,4.18,-4.78,1
,Cc1cc(OCc2nnc(SC3CCCC3)n2-c2cccnc2)ccc1-c1ccc(S(C)(=O)=O)cc1,,Cc1cc(OCc2nnc(SC3CCCC3)n2-c2cccnc2)ccc1-c1ccc(S(C)(=O)=O)cc1,,NMS-873,NCGC00371131-09,MODERATE,HIGH,4.62,-5.34,1
1487.0,CC(CC(C#N)(c1ccccc1)C(C)C)N(C)C,,CC(CC(C#N)(c1ccccc1)C(C)C)N(C)C,isoaminile,Isoaminile,,LOW,INACTIVE,3.41,-3.56,0
2245.0,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,prednisolone,Prednisolone,NCGC00179649-13,LOW,INACTIVE,1.64,-3.18,0
1672.0,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,melatonin,Melatonin,NCGC00015680-33,LOW,MODERATE,1.42,-3.21,0
5288.0,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)cc1O,cannabidiol,Cannabidiol,,MODERATE,HIGH,6.1,-4.39,1
336.0,NS(=O)(=O)c1cc2c(cc1Cl)NC(Cc1ccccc1)NS2(=O)=O,,NS(=O)(=O)c1cc2c(cc1Cl)NC(Cc1ccccc1)NS2(=O)=O,benzylhydrochlorothiazide,Benzylhydrochlorothiazide,,LOW,INACTIVE,1.31,-3.34,0
4110.0,Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1,,Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1,tolvaptan,Tolvaptan,,MODERATE,HIGH,4.14,-5.56,1
119.0,COCCCOc1cc(CC(CC(N)C(O)CC(C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC,,COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC,aliskiren,Aliskiren hemifumarate,NCGC00186464-04,LOW,INACTIVE,3.85,-5.44,0
382.0,CC(=O)Oc1ccc(C2(c3ccc(OC(C)=O)cc3)Oc3ccccc3NC2=O)cc1,,CC(=O)Oc1ccc(C2(c3ccc(OC(C)=O)cc3)Oc3ccccc3NC2=O)cc1,bisoxatin acetate,Bisoxatin acetate,,MODERATE,HIGH,4.14,-5.5,1
1944.0,O=C1CCCC(=O)C1C(=O)c1ccc(C(F)(F)F)cc1[N+](=O)[O-],,O=C1CCCC(=O)C1C(=O)c1ccc(C(F)(F)F)cc1[N+](=O)[O-],nitisinone,Nitisinone,NCGC00185778-06,LOW,INACTIVE,2.06,-4.61,0
384.0,Cc1ccc(C(=O)Oc2ccc(C(O)CNC(C)(C)C)cc2OC(=O)c2ccc(C)cc2)cc1,,Cc1ccc(C(=O)Oc2ccc(C(O)CNC(C)(C)C)cc2OC(=O)c2ccc(C)cc2)cc1,bitolterol,Bitolterol,,HIGH,HIGH,4.54,-5.98,1
1595.0,COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC,,COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC,lomerizine,Lomerizine dihydrochloride,,LOW,MODERATE,4.39,-4.84,0
183.0,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,amlodipine,Amlodipine,,MODERATE,LOW,2.22,-4.74,1
5203.0,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,rucaparib,Rucaparib,,HIGH,HIGH,2.39,-4.45,1
1933.0,CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,,CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,nilutamide,Nilutamide,NCGC00015754-17,LOW,INACTIVE,1.74,-4.88,0
660.0,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,cisapride,Cisapride,,LOW,INACTIVE,2.92,-4.59,0
1507.0,CC(CN1c2ccccc2Sc2cccnc21)N(C)C,,CC(CN1c2ccccc2Sc2cccnc21)N(C)C,isothipendyl,Isothipendyl hydrochloride,,LOW,INACTIVE,3.6,-3.31,0
957.0,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)C=CC(C)C(C)C)CC(O)CC1O,,C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@H](C)C(C)C)C[C@@H](O)C[C@@H]1O,doxercalciferol,Doxercalciferol,NCGC00182058-03,HIGH,HIGH,6.28,-5.41,1
,NC(=O)c1ccc(I)c([N+](=O)[O-])c1,,NC(=O)c1ccc(I)c([N+](=O)[O-])c1,,Iniparib,,LOW,INACTIVE,1.38,-3.35,0
,Cn1cc(CNCC2CCN(c3ncc(C(=O)NO)cn3)CC2)c2ccccc21,,Cn1cc(CNCC2CCN(c3ncc(C(=O)NO)cn3)CC2)c2ccccc21,,Quisinostat,NCGC00346487-03,MODERATE,LOW,2.04,-3.74,1
5262.0,COc1cccc(N2CCN(C3=Nc4c(F)cccc4C(CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1,,COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1,letermovir,Letermovir,,MODERATE,HIGH,4.58,-4.76,1
1434.0,CC(C)NCCCC1(C(N)=O)c2ccccc2-c2ccccc21,,CC(C)NCCCC1(C(N)=O)c2ccccc2-c2ccccc21,indecainide,Indecainide,,LOW,INACTIVE,3.25,-5.54,0
,COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cccc4c(=O)c5cccc(OC)c5[nH]c34)cc1)CC2,,COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cccc4c(=O)c5cccc(OC)c5[nH]c34)cc1)CC2,,Elacridar,,HIGH,HIGH,5.46,-5.3,1
2875.0,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,zotepine,Zotepine,,MODERATE,HIGH,4.74,-5.63,1
1524.0,O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1,,O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1,ketanserin,Ketanserin,,LOW,INACTIVE,2.93,-3.41,0
2168.0,CCC1C=C(C)CC(C)CC(OC)C2OC(O)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C)=CC3CCC(Cl)C(OC)C3)C(C)C(O)CC1=O)C(C)CC2OC,,CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@H](Cl)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,pimecrolimus,Pimecrolimus,,HIGH,HIGH,4.34,-5.74,1
,O=C(Oc1cccc2cccnc12)c1ccccc1,,O=C(Oc1cccc2cccnc12)c1ccccc1,,Benzoxiquine,,LOW,INACTIVE,3.48,-3.94,0
3931.0,O=C(OC1CC2CC3CC(C1)N2CC3=O)c1c[nH]c2ccccc12,,O=C(O[C@@H]1C[C@@H]2CC3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12,dolasetron,Dolasetron mesylate hydrate,,LOW,INACTIVE,2.41,-3.09,0
1611.0,CCOC(=O)OC1(C(=O)OCCl)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,,CCOC(=O)O[C@]1(C(=O)OCCl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,loteprednol etabonate,Loteprednol etabonate,NCGC00164594-08,LOW,INACTIVE,3.08,-4.83,0
3601.0,CN(C)C(=S)SSC(=S)N(C)C,,CN(C)C(=S)SSC(=S)N(C)C,thiram,Thiram,,LOW,INACTIVE,2.18,-3.74,0
,O=C(O)c1ccnc2cc(C(OCCN3CCCCC3)c3ccccc3Cl)[nH]c12,,O=C(O)c1ccnc2cc(C(OCCN3CCCCC3)c3ccccc3Cl)[nH]c12,,,"NCGC00479258-01, NCGC00479257-01",LOW,INACTIVE,3.7,-4.11,0
1581.0,CCCCC(C)CC(O)C=CC1C(O)CC(=O)C1CCCCC=CC(=O)O,,CCCC[C@H](C)C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC/C=C/C(=O)O,limaprost,Limaprost,,LOW,MODERATE,4.0,-4.23,0
125.0,C=CCC1(O)CCC2C3CCC4=CCCCC4C3CCC21C,,C=CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C,allylestrenol,Allylestrenol,,LOW,INACTIVE,5.14,-5.73,0
,COc1c(O)cc2oc3cc(O)c(CC=C(C)C)c(O)c3c(=O)c2c1CC=C(C)C,,COc1c(O)cc2oc3cc(O)c(CC=C(C)C)c(O)c3c(=O)c2c1CC=C(C)C,,alpha-MANGOSTIN,,HIGH,HIGH,4.42,-4.64,1
1137.0,Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O,,Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O,febuxostat,Febuxostat,NCGC00182059-11,MODERATE,HIGH,3.8,-4.24,1
1042.0,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,,C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,ergometrine,Ergobasine,,MODERATE,LOW,1.53,-3.0,1
,CC(C)=CCCC(C)=CCCC(C)=CC=CC(C)=CC(=O)O,,CC(C)=CCC/C(C)=C/CC/C(C)=C/C=C/C(C)=C/C(=O)O,,PERETINOIN,,LOW,INACTIVE,6.27,-4.87,0
,S=C(SSC(=S)N1CCCCC1)N1CCCCC1,,S=C(SSC(=S)N1CCCCC1)N1CCCCC1,,Dicyclopentamethylenethiuram disulfide,,LOW,INACTIVE,3.78,-4.67,0
610.0,COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1,,COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1,chlorotrianisene,Chlorotrianisene,,MODERATE,HIGH,5.95,-6.28,1
1968.0,C#CC1(OC(C)=O)CCC2C3CCC4=CC(=NO)CCC4C3CCC21CC,,C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC,norgestimate,Norgestimate,,HIGH,HIGH,3.8,-4.85,1
419.0,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,budesonide,Budesonide,NCGC00161834-01,LOW,INACTIVE,2.43,-3.97,0
,Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1,,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,,Resveratrol,NCGC00017352-22,HIGH,HIGH,2.57,-3.52,1
2445.0,CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,simvastatin,Simvastatin,NCGC00017324-15,MODERATE,LOW,4.51,-4.56,1
,CC#Cc1cncc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)C2(CCC(OC)CC2)C3)c1,,CC#Cc1cncc(-c2ccc3c(c2)[C@@]2(N=C(C)C(N)=N2)C2(CCC(OC)CC2)C3)c1,,LY-3314814,,LOW,INACTIVE,4.46,-5.2,0
2035.0,COc1cc2[nH]c(C)c(CCN3CCN(c4ccccc4)CC3)c2cc1OC,,COc1cc2[nH]c(C)c(CCN3CCN(c4ccccc4)CC3)c2cc1OC,oxypertine,Oxypertine hydrochloride,,HIGH,HIGH,4.35,-4.05,1
,C=C(C)C1Cc2c(ccc3c2OC2COc4cc(OC)c(OC)cc4C2C3=O)O1,,C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1,,Rotenone,,HIGH,HIGH,2.3,-4.49,1
555.0,COCC1=C(C(=O)OC(C)OC(=O)OC(C)C)N2C(=O)C(NC(=O)C(=NOC)c3csc(N)n3)C2SC1,,COCC1=C(C(=O)OC(C)OC(=O)OC(C)C)N2C(=O)[C@@H](NC(=O)/C(=N\OC)c3csc(N)n3)[C@H]2SC1,cefpodoxime proxetil,CEFPODOXIME PROXETIL,,MODERATE,LOW,1.71,-4.04,1
1007.0,COc1ccc(C(=O)Nc2ccccc2CCC2CCCCN2C)cc1,,COc1ccc(C(=O)Nc2ccccc2CCC2CCCCN2C)cc1,encainide,Encainide hydrochloride,,LOW,INACTIVE,4.29,-4.94,0
2708.0,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,torsemide,Torsemide,,LOW,INACTIVE,1.76,-3.77,0
5154.0,COCC1CC(c2nc(-c3ccc4c(c3)COc3cc5c(ccc6nc(C7CCC(C)N7C(=O)C(NC(=O)OC)C(C)C)[nH]c65)cc3-4)c[nH]2)N(C(=O)C(NC(=O)OC)c2ccccc2)C1,,COC[C@H]1C[C@@H](c2nc(-c3ccc4c(c3)COc3cc5c(ccc6nc([C@@H]7CC[C@H](C)N7C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c65)cc3-4)c[nH]2)N(C(=O)[C@H](NC(=O)OC)c2ccccc2)C1,velpatasvir,Velpatasvir|VELPATASVIR,,HIGH,HIGH,5.41,-5.2,1
2494.0,CC(=C(CCOC(=O)C(C)C)SSC(CCOC(=O)C(C)C)=C(C)N(C=O)Cc1cnc(C)nc1N)N(C=O)Cc1cnc(C)nc1N,,C/C(=C(\CCOC(=O)C(C)C)SS/C(CCOC(=O)C(C)C)=C(/C)N(C=O)Cc1cnc(C)nc1N)N(C=O)Cc1cnc(C)nc1N,sulbutiamine,Bisibutiamine,,MODERATE,LOW,3.15,-4.19,1
3550.0,CCCCC(CC)CCC(CC(C)C)OS(=O)(=O)O,,CCCCC(CC)CCC(CC(C)C)OS(=O)(=O)O,sodium tetradecyl sulfate,SODIUM TETRADECYL SULFATE,,MODERATE,HIGH,1.97,-4.45,1
,Oc1c(Br)cc(Br)cc1CNC1CCC(O)CC1,,Oc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1,,,NCGC00538143-01,MODERATE,HIGH,2.45,-3.92,1
2313.0,CC1OC(OC2C=C3CCC4C(CCC5(C)C(c6ccc(=O)oc6)CCC45O)C3(C)CC2)C(O)C(O)C1O,,C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O,proscillaridin,Proscillaridin,NCGC00016447-01,LOW,INACTIVE,2.37,-4.09,0
,O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O,,O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O,,Tribromsalan,,HIGH,HIGH,5.48,-5.29,1
343.0,CC#CCC(C)C(O)C=CC1C(O)CC2Oc3c(CCCC(=O)O)cccc3C21,,CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2c3cccc(CCCC(=O)O)c3O[C@H]2C[C@H]1O,beraprost,Beraprost sodium,,MODERATE,HIGH,3.44,-4.6,1
2847.0,CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,,CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,warfarin,Warfarin sodium,NCGC00094810-08,LOW,INACTIVE,2.41,-3.82,0
1229.0,CC(C)n1c(C=CC(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21,,CC(C)n1c(/C=C/[C@H](O)C[C@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21,fluvastatin,Fluvastatin Na,NCGC00164604-06,MODERATE,LOW,3.69,-4.97,1
,CC(=O)OC1CCC2C3CCC4=CC(=O)CCC4=C3C=CC12C,,CC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@]12C,,Trenbolone (acetate),,HIGH,HIGH,3.46,-4.61,1
1207.0,O=C1OC2(c3ccc([O-])cc3Oc3cc([O-])ccc32)c2ccccc21,,O=C1OC2(c3ccc([O-])cc3Oc3cc([O-])ccc32)c2ccccc21,fluorescein,Fluorescein sodium,,LOW,INACTIVE,2.63,-4.12,0
1556.0,N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,,N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,letrozole,Letrozole,NCGC00016973-08,LOW,INACTIVE,1.87,-3.55,0
2129.0,CN1CCC2=C(C1)C(c1ccccc1)c1ccccc12,,CN1CCC2=C(C1)C(c1ccccc1)c1ccccc12,phenindamine,PHENINDAMINE,,LOW,INACTIVE,4.13,-3.97,0
2675.0,Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1,,Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1,tioconazole,Tioconazole,,HIGH,HIGH,5.12,-4.37,1
,CCC(C(=O)C(C)C(O)C(C)CCc1ccc(C)c(O)c1C(=O)[O-])C1OC(CC)(C2CCC(O)(CC)C(C)O2)CC1C,,CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C(=O)[O-])[C@H]1O[C@](CC)([C@H]2CC[C@](O)(CC)[C@H](C)O2)C[C@@H]1C,,,NCGC00095029-08,HIGH,HIGH,4.91,-5.16,1
,Cc1ccc(N)cc1C(=O)NC(C)c1cccc2ccccc12,,Cc1ccc(N)cc1C(=O)N[C@H](C)c1cccc2ccccc12,,,NCGC00188640-01,HIGH,HIGH,3.79,-5.73,1
4185.0,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,vemurafenib,Vemurafenib,NCGC00250399-02,HIGH,HIGH,4.96,-6.13,1
778.0,CCN(CC)CCS(=O)(=O)C1CN2CC1C(=O)OC(C(C)C)C(C)C=CC(=O)NCC=CC(C)=CC(O)CC(=O)Cc1nc(co1)C2=O,,CCN(CC)CCS(=O)(=O)[C@H]1CN2C[C@H]1C(=O)O[C@H](C(C)C)[C@H](C)/C=C/C(=O)NC/C=C/C(C)=C/[C@@H](O)CC(=O)Cc1nc(co1)C2=O,dalfopristin,Dalfopristin,,HIGH,HIGH,2.45,-3.96,1
4876.0,O=C(C=Cc1cccc(S(=O)(=O)Nc2ccccc2)c1)NO,,O=C(C=Cc1cccc(S(=O)(=O)Nc2ccccc2)c1)NO,belinostat,Belinostat,,MODERATE,HIGH,1.73,-4.05,1
1383.0,CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12,,CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12,hycanthone,Hycanthone,,MODERATE,HIGH,3.87,-4.33,1
2858.0,CC(C(=O)O)c1ccc2c(c1)CC(=O)c1ccccc1S2,,CC(C(=O)O)c1ccc2c(c1)CC(=O)c1ccccc1S2,zaltoprofen,Zaltoprofen,NCGC00183878-01,LOW,INACTIVE,3.55,-4.33,0
1400.0,OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,,OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,hydroxyzine,Hydroxyzine,,HIGH,HIGH,3.43,-3.61,1
4810.0,C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,ibrutinib,Ibrutinib (PCI-32765),NCGC00187912-13,MODERATE,LOW,2.76,-4.33,1
3408.0,Clc1ccc(CON=C(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,,Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,oxiconazole,Oxiconazole nitrate,,HIGH,HIGH,5.43,-5.35,1
,O=C(OCC1OC(OC(=O)c2cc(O)c(O)c(O)c2)C(OC(=O)c2cc(O)c(O)c(O)c2)C(OC(=O)c2cc(O)c(O)c(O)c2)C1OC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,,O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,,Penta-O-galloyl-Î²-D-glucose hydrate,,HIGH,HIGH,3.43,-3.14,1
2543.0,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,sumatriptan,Sumatriptan,,LOW,INACTIVE,1.17,-3.37,0
,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)c1ccncc1,,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccncc1,,Dexamethasone isonicotinate,,MODERATE,HIGH,2.62,-4.3,1
,CNC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(=O)NO)CC(C)C,,CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CC(=O)NO)CC(C)C,,"Ilomastat (GM6001, Galardin)",,LOW,MODERATE,1.23,-3.98,0
3272.0,Cc1ccc(C(C)C)cc2c(C)ccc1-2,,Cc1ccc(C(C)C)cc2c(C)ccc1-2,guaiazulen,Guaiazulene,,HIGH,HIGH,5.0,-3.15,1
,NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCN4)cc3F)nc12,,NC(=O)c1cccc2[nH]c(-c3ccc([C@@H]4CCCN4)cc3F)nc12,,A-966492,NCGC00345451-04,LOW,INACTIVE,2.34,-4.19,0
,Cc1c(-c2cnccn2)ssc1=S,,Cc1c(-c2cnccn2)ssc1=S,,Oltipraz,NCGC00387263-04,MODERATE,LOW,1.77,-3.22,1
2135.0,O=C1OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21,,O=C1OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21,phenolphthalein,Phenolphthalein,,LOW,HIGH,4.41,-4.51,0
2377.0,COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(c(C=NN5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C,,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(C=NN5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,rifampicin,Rifampicin,NCGC00022678-08,HIGH,HIGH,3.74,-4.3,1
,CC(=O)OC1CC2(C)C(CC(O)C3C4(C)CCC(O)C(C)C4CCC32C)C1=C(CCC=C(C)C)C(=O)[O-],,CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)[O-],,Fusidic Acid (sodium salt),,MODERATE,HIGH,4.97,-5.04,1
1810.0,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,miltefosine,Miltefosine,,LOW,INACTIVE,2.31,-6.05,0
1211.0,OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,,OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,flupentixol,cis-Flupentixol,,HIGH,HIGH,4.56,-5.04,1
2351.0,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,raloxifene,Raloxifene hydrochloride,NCGC00015889-21,HIGH,HIGH,5.44,-5.97,1
4172.0,CC(C)(C)NC(=O)NC(C(=O)N1CC2C(C1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C,,CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C,boceprevir,Boceprevir,,LOW,INACTIVE,1.92,-4.35,0
4161.0,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(OC(=O)C(C)(CO)CO)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,temsirolimus,Temsirolimus,NCGC00167518-12,MODERATE,LOW,4.37,-5.66,1
597.0,N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,,N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,chlorhexidine,Chlorhexidine|Chlorhexidine HCl,NCGC00016246-10,MODERATE,HIGH,2.71,-4.31,1
939.0,CC(=O)OC12COC1CC(O)C1(C)C(=O)C(O)C3=C(C)C(OC(=O)C(O)C(NC(=O)OC(C)(C)C)c4ccccc4)CC(O)(C(OC(=O)c4ccccc4)C21)C3(C)C,,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,docetaxel,Docetaxel,,MODERATE,HIGH,2.59,-4.8,1
3095.0,Cc1ccc2c(Cl)cc(Cl)c(O)c2n1,,Cc1ccc2c(Cl)cc(Cl)c(O)c2n1,chlorquinaldol,"5,7-Dichloro-8-hydroxy-2-methylquinoline",,LOW,INACTIVE,3.82,-3.63,0
3630.0,O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1,,O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1,triclocarban,Triclocarban,,MODERATE,LOW,5.1,-5.04,1
1395.0,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,hydroxychloroquine,Hydroxychloroquine sulfate,NCGC00159483-06,LOW,INACTIVE,3.87,-4.12,0
1490.0,Cc1cc(C(=O)NNCc2ccccc2)no1,,Cc1cc(C(=O)NNCc2ccccc2)no1,isocarboxazid,Isocarboxazid,,LOW,INACTIVE,1.18,-3.01,0
,CCCCCCCCCCCCNCCNCCNCC(=O)O,,CCCCCCCCCCCCNCCNCCNCC(=O)O,,,NCGC00274269-01,LOW,INACTIVE,2.05,-4.36,0
942.0,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,dofetilide,Dofetilide,NCGC00164549-12,LOW,INACTIVE,2.17,-4.35,0
,CCCCCCC1C(=O)OC(C)C(NC(=O)c2cccc(NC=O)c2O)C(=O)OC(C)C1OC(=O)CC(C)C,,CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C,,Antimycin A,,HIGH,HIGH,3.43,-4.4,1
5081.0,C=CC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OC1CC1CCCCCc1nc3ccc(OC)cc3nc1O2)C(=O)NS(=O)(=O)C1CC1,,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)O[C@@H]1C[C@H]1CCCCCc1nc3ccc(OC)cc3nc1O2)C(=O)NS(=O)(=O)C1CC1,grazoprevir,MK-5172,,MODERATE,HIGH,2.94,-4.87,1
1216.0,CC12C=CC(=O)C=C1C(F)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,,C[C@]12C[C@H](O)[C@H]3[C@@H](C[C@H](F)C4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,fluprednisolone,Fluprednisolone,,LOW,INACTIVE,1.24,-3.17,0
2087.0,O=[N+]([O-])OCC(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-],,O=[N+]([O-])OCC(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-],pentaerithrityl tetranitrate,Pentaerythritol tetranitrate,,LOW,INACTIVE,1.62,-3.38,0
2274.0,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,prochlorperazine,Prochlorperazine dimaleate,,MODERATE,HIGH,4.67,-4.53,1
341.0,O=C(O)CCCN1CCC(OC(c2ccc(Cl)cc2)c2ccccn2)CC1,,O=C(O)CCCN1CCC(O[C@@H](c2ccc(Cl)cc2)c2ccccn2)CC1,bepotastine,Bepotastine (Beslilate),,LOW,INACTIVE,3.64,-3.89,0
3137.0,N=C(N)c1ccc(OCCCOc2ccc(C(=N)N)cc2Br)c(Br)c1,,N=C(N)c1ccc(OCCCOc2ccc(C(=N)N)cc2Br)c(Br)c1,dibrompropamidine,Dibromopropamidine dihydrochloride,,LOW,INACTIVE,2.35,-4.56,0
,CC(C)C(=O)OCc1cccc(OC(=O)C2N3C(=O)C(NC(=O)Cc4ccccc4)C3SC2(C)C)c1,,CC(C)C(=O)OCc1cccc(OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)Cc4ccccc4)[C@H]3SC2(C)C)c1,,Tobicillin,,MODERATE,LOW,3.87,-5.31,1
,CC(=O)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C,,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,,Pregnenolone,NCGC00163125-13,LOW,INACTIVE,4.06,-4.38,0
,O=C(NCc1ccco1)c1ccc2c(c1)N(Cc1c(F)cccc1Cl)C(=O)CS2,,O=C(NCc1ccco1)c1ccc2c(c1)N(Cc1c(F)cccc1Cl)C(=O)CS2,,STING agonist G10,,MODERATE,HIGH,3.55,-4.41,1
4813.0,N#CC(=C1SCC(c2ccc(Cl)cc2Cl)S1)n1ccnc1,,N#C/C(=C1/SC[C@@H](c2ccc(Cl)cc2Cl)S1)n1ccnc1,luliconazole,Luliconazole,,MODERATE,HIGH,4.25,-3.73,1
2419.0,OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O,,OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O,salmeterol,Salmeterol xinafoate,,MODERATE,HIGH,3.82,-5.27,1
,O=c1c(O)c(-c2ccc(O)cc2)oc2ccccc12,,O=c1c(O)c(-c2ccc(O)cc2)oc2ccccc12,,"3,4 -DIHYDROXYFLAVONE",,MODERATE,HIGH,2.93,-3.48,1
,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=NC(CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2,,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2,,OTX-015,NCGC00356067-11,HIGH,HIGH,4.04,-4.57,1
741.0,O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1,,O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1,cromoglicic acid,Sodium cromoglycate,,LOW,INACTIVE,1.84,-4.12,0
,Cc1cc(CC(C)C[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C)c(O)c(-n2nc3ccccc3n2)c1,,Cc1cc(CC(C)C[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C)c(O)c(-n2nc3ccccc3n2)c1,,DROMETRIZOLE TRISILOXANE,,LOW,INACTIVE,6.49,-5.85,0
98.0,Cc1ccccc1-n1c(CF)nc2ccc(N)cc2c1=O,,Cc1ccccc1-n1c(CF)nc2ccc(N)cc2c1=O,afloqualone,Afloqualone,,MODERATE,HIGH,2.16,-3.56,1
756.0,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,cyclopenthiazide,Cyclopenthiazide,,LOW,INACTIVE,1.88,-3.13,0
977.0,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,ebastine,Ebastine,,LOW,INACTIVE,6.9,-6.86,0
,CCNC(=O)NCCCOc1cccc(CN2CCCCC2)c1,,CCNC(=O)NCCCOc1cccc(CN2CCCCC2)c1,,Dalcotidine,,LOW,INACTIVE,2.61,-3.23,0
,CC1=CC(=C(c2ccc(N)cc2)c2ccc(N)cc2)C=CC1=N,,CC1=CC(=C(c2ccc(N)cc2)c2ccc(N)cc2)C=CC1=N,,C.I. Basic Violet 14,,HIGH,HIGH,3.42,-4.63,1
2218.0,CC(C)(C)C(=O)OCOC(=O)C1N2C(=O)C(NC(=O)C(N)c3ccccc3)C2SC1(C)C,,CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C,pivampicillin,Pivampicillin,,HIGH,HIGH,1.43,-4.12,1
,CCCC(NC(=O)C(C#N)=Cc1cccc(Br)n1)c1ccccc1,,CCC[C@H](NC(=O)/C(C#N)=C/c1cccc(Br)n1)c1ccccc1,,Degrasyn,,MODERATE,HIGH,4.31,-5.05,1
,O=C(C=Cc1ccccc1)OCc1ccccc1,,O=C(/C=C/c1ccccc1)OCc1ccccc1,,Benzyl cinnamate,,HIGH,LOW,4.03,-4.85,1
,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,,CCN(CC)C(=O)N[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@@H]2N(C)C1,,"(-)-(5S,8R)-Lisuride",,HIGH,LOW,2.38,-3.38,1
1665.0,OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1,,O[C@@H](c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[C@H]1CCCCN1,mefloquine,Mefloquine hydrochloride,NCGC00094994-10,LOW,INACTIVE,3.1,-4.01,0
2812.0,CC(C(=O)O)c1ccc(C2CCCCC2)c2ccccc12,,CC(C(=O)O)c1ccc(C2CCCCC2)c2ccccc12,vedaprofen,Quadrisol,,LOW,MODERATE,5.25,-6.1,0
3429.0,FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,,FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,perflexane,Perflexane,,LOW,INACTIVE,4.19,-3.98,0
5022.0,O=c1[nH]c2ccccc2n1CCN1CCN(c2cccc(C(F)(F)F)c2)CC1,,O=c1[nH]c2ccccc2n1CCN1CCN(c2cccc(C(F)(F)F)c2)CC1,flibanserin,FLIBANSERIN,,LOW,MODERATE,3.34,-3.34,0
2303.0,CC(C)NCC(O)COc1cccc2ccccc12,,CC(C)NCC(O)COc1cccc2ccccc12,propranolol,Dexpropranolol|Propranolol HCl,,LOW,INACTIVE,3.03,-3.53,0
2014.0,O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,,O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,oxatomide,Oxatomide,,MODERATE,HIGH,4.72,-4.04,1
2277.0,Nc1ccc2cc3ccc(N)cc3nc2c1,,Nc1ccc2cc3ccc(N)cc3nc2c1,proflavine,Proflavin hemisulfate,,HIGH,HIGH,2.1,-3.3,1
348.0,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,betamethasone,Dexamethasone,"NCGC00091019-19, NCGC00093684-06",LOW,INACTIVE,1.96,-3.89,0
4242.0,COc1ccc(C(=O)CC(=O)c2ccc(C(C)(C)C)cc2)cc1,,COc1ccc(C(=O)CC(=O)c2ccc(C(C)(C)C)cc2)cc1,avobenzone,Avobenzone,NCGC00095112-07,LOW,INACTIVE,4.98,-5.7,0
5274.0,O=C(NCc1c(F)cc(F)cc1F)c1cn2c(c(O)c1=O)C(=O)N1C3CCC(C3)OC1C2,,O=C(NCc1c(F)cc(F)cc1F)c1cn2c(c(O)c1=O)C(=O)N1[C@H]3CC[C@H](C3)O[C@@H]1C2,bictegravir,Bictegravir,,HIGH,HIGH,1.28,-3.91,1
2840.0,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)C,,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C,colecalciferol,CHOLECALCIFEROL,,HIGH,HIGH,7.98,-6.0,1
5241.0,COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1,,COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1,betrixaban,Betrixaban,,MODERATE,LOW,2.86,-4.44,1
2742.0,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,triflupromazine,Triflupromazine hydrochloride,,MODERATE,HIGH,4.95,-5.29,1
4812.0,COc1ccc2c(OC3CC4C(=O)NC5(C(=O)NS(=O)(=O)C6CC6)CC5C=CCCCCN(C)C(=O)C4C3)cc(-c3nc(C(C)C)cs3)nc2c1C,,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)cc(-c3nc(C(C)C)cs3)nc2c1C,simeprevir,Simeprevir,,HIGH,HIGH,4.69,-5.41,1
1663.0,Cc1cccc(Nc2ccccc2C(=O)O)c1C,,Cc1cccc(Nc2ccccc2C(=O)O)c1C,mefenamic acid,Mefenamic acid,,MODERATE,HIGH,4.52,-4.25,1
700.0,CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1,,CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1,clomifene,Clomifene citrate,NCGC00164385-06,HIGH,HIGH,6.63,-5.99,1
647.0,CC(NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12,,C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12,cinacalcet,Cinacalcet hydrochloride,NCGC00181002-10,LOW,INACTIVE,5.49,-6.8,0
,COc1cc(CC2C(=O)OCC2Cc2ccc(OC)c(OC)c2)ccc1O,,COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O,,Arctigenin,,LOW,INACTIVE,3.19,-4.54,0
953.0,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,doxapram,Doxapram hydrochloride,,LOW,INACTIVE,3.65,-4.04,0
,CC12Cc3nonc3CC1CCC1C2CCC2(C)C1CCC2(C)O,,C[C@]12Cc3nonc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,,Furazabol,,LOW,INACTIVE,4.3,-4.08,0
,O=C(C=Cn1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1ccccn1,,O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1ccccn1,,Verdinexor,NCGC00386421-05,HIGH,HIGH,3.7,-5.0,1
549.0,CC(OC(=O)OC1CCCCC1)OC(=O)C1=C(CSc2nnnn2CCN(C)C)CSC2C(NC(=O)Cc3csc(N)n3)C(=O)N12,,CC(OC(=O)OC1CCCCC1)OC(=O)C1=C(CSc2nnnn2CCN(C)C)CS[C@@H]2[C@H](NC(=O)Cc3csc(N)n3)C(=O)N12,cefotiam hexetil,SCE 2174,,MODERATE,HIGH,2.1,-3.79,1
,CC(C)=CCC(O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,,CC(C)=CC[C@@H](O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,,Shikonin,NCGC00163489-03,HIGH,HIGH,2.19,-3.09,1
,CC(=O)Nc1ccc(S(=O)(=O)Nc2cc(C)on2)cc1,,CC(=O)Nc1ccc(S(=O)(=O)Nc2cc(C)on2)cc1,,N-Acetyl sulfamethoxazole,,LOW,INACTIVE,1.54,-3.04,0
,Cc1noc2c1-c1ccccc1C(c1ccc(Cl)cc1)=NC2CC(N)=O,,Cc1noc2c1-c1ccccc1C(c1ccc(Cl)cc1)=N[C@H]2CC(N)=O,,CPI-0610,,LOW,LOW,4.05,-4.27,0
1847.0,O=C1NC2CCCCN2C12CCN(CCCN1c3ccccc3CCc3ccc(Cl)cc31)CC2,,O=C1NC2CCCCN2C12CCN(CCCN1c3ccccc3CCc3ccc(Cl)cc31)CC2,mosapramine,Mosapramine,,HIGH,HIGH,4.68,-4.43,1
5286.0,CON=C1CC2(CC3CC(CC=C(C)CC(C)C=CC=C4COC5C(O)C(C)=CC(C(=O)O3)C45O)O2)OC(C(C)=CC(C)C)C1C,,CO/N=C1\C[C@]2(C[C@@H]3C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C4\CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@H](/C(C)=C/C(C)C)[C@H]1C,moxidectin,Moxidectin,,HIGH,HIGH,5.3,-5.09,1
4176.0,CC(=O)OC1CCC2(C)C(=CCC3C2CCC2(C)C(c4cccnc4)=CCC32)C1,,CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC=C(c5cccnc5)[C@@]4(C)CC[C@@H]32)C1,abiraterone acetate,Abiraterone acetate,,LOW,MODERATE,5.63,-5.59,0
3783.0,CC(C)CCCC(C)NC(C)C,,CC(C)CCCC(C)NC(C)C,iproheptine,IPROHEPTINE,,LOW,INACTIVE,3.8,-3.48,0
,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,,Propionylpromazine hydrochloride,,LOW,INACTIVE,4.75,-4.8,0
,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,,Entinostat,NCGC00165833-10,LOW,INACTIVE,2.06,-4.82,0
4225.0,CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1,,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,axitinib,Axitinib,NCGC00241108-15,MODERATE,HIGH,4.17,-5.84,1
2763.0,Cc1ccc(C(=CCN2CCCC2)c2ccccn2)cc1,,Cc1ccc(/C(=C\CN2CCCC2)c2ccccn2)cc1,triprolidine,Triprolidine,,LOW,INACTIVE,4.14,-3.71,0
4150.0,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,rimonabant,Rimonabant,NCGC00164572-14,HIGH,LOW,5.47,-5.36,1
,N#CC(c1ccc(Cl)cc1)c1c(Cl)cc(-n2ncc(=O)[nH]c2=O)cc1Cl,,N#CC(c1ccc(Cl)cc1)c1c(Cl)cc(-n2ncc(=O)[nH]c2=O)cc1Cl,,Diclazuril,NCGC00168785-05,HIGH,HIGH,4.09,-5.18,1
2583.0,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,telmisartan,Telmisartan,,HIGH,HIGH,6.66,-5.16,1
2269.0,CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1,,CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1,probucol,Probucol,,LOW,MODERATE,8.92,-7.09,0
722.0,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,clozapine,Clozapine,NCGC00015254-30,LOW,INACTIVE,3.8,-3.25,0
621.0,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,chlorpromazine,Chlorpromazine|Chlorpromazine hydrochloride,,MODERATE,HIGH,5.26,-4.88,1
369.0,CNCCCCOc1ccccc1Cc1ccccc1,,CNCCCCOc1ccccc1Cc1ccccc1,bifemelane,Bifemelane,,LOW,INACTIVE,3.67,-5.22,0
2727.0,CC(=O)OCC(=O)C1(O)C(OC(C)=O)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,,CC(=O)OCC(=O)[C@@]1(O)[C@H](OC(C)=O)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,triamcinolone diacetate,Triamcinolone diacetate,,LOW,INACTIVE,2.05,-4.31,0
5259.0,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,abemaciclib,Abemaciclib,NCGC00351599-03,LOW,MODERATE,4.25,-4.5,0
946.0,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,donepezil,Donepezil hydrochloride,,LOW,INACTIVE,4.14,-4.93,0
1032.0,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13,,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CCC(=O)O4)[C@H]13,eplerenone,Eplerenone,NCGC00159559-10,LOW,INACTIVE,1.67,-4.66,0
1881.0,CCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4C3CCC12C,,CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C,nandrolone decanoate,Nandrolone decanoate,,LOW,INACTIVE,6.05,-6.44,0
2595.0,CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O,,CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O,tenoxicam,Tenoxicam,NCGC00016889-15,LOW,INACTIVE,2.42,-3.12,0
1481.0,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,irbesartan,Irbesartan,,MODERATE,LOW,4.12,-4.7,1
,CCOC(=O)C=C(C)C=CCC(C)CCCC(C)C,,CCOC(=O)/C=C(C)/C=C/C[C@@H](C)CCCC(C)C,,S-Hydroprene,,LOW,INACTIVE,6.22,-5.44,0
,CC(=O)c1cc([N+](=O)[O-])c(Sc2ccc(F)cc2F)s1,,CC(=O)c1cc([N+](=O)[O-])c(Sc2ccc(F)cc2F)s1,,P 22077,,LOW,INACTIVE,3.66,-5.05,0
,O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1,,O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1,,GSK-650394,,HIGH,HIGH,5.65,-6.16,1
80.0,CCC1(O)CC(OC2CC(N(C)C)C(OC3CC(O)C(OC4CCC(=O)C(C)O4)C(C)O3)C(C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)C1C(=O)OC,,CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC,aclarubicin,Aclarubicin,,HIGH,HIGH,2.79,-3.57,1
4452.0,CCC(=O)OC1(C(=O)CCl)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,clobetasol propionate,Clobetasol propionate,NCGC00023373-10,LOW,INACTIVE,3.49,-5.05,0
99.0,COc1ccc2cccc(CCNC(C)=O)c2c1,,COc1ccc2cccc(CCNC(C)=O)c2c1,agomelatine,Agomelatine,NCGC00253646-08,LOW,INACTIVE,2.83,-4.5,0
,Nc1ccc(C(=O)Nc2cccc(-c3nc(N4CCOCC4)c4oc5ncccc5c4n3)c2)cn1,,Nc1ccc(C(=O)Nc2cccc(-c3nc(N4CCOCC4)c4oc5ncccc5c4n3)c2)cn1,,YM-201636,,HIGH,HIGH,3.23,-3.58,1
2426.0,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCC(O)C(C)(C)O,,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CC[C@@H](O)C(C)(C)O,secalciferol,"(24S)-24,25-Dihydroxyvitamin D3",,MODERATE,HIGH,5.46,-4.71,1
1154.0,CC(C(=O)O)c1cccc(Oc2ccccc2)c1,,CC(C(=O)O)c1cccc(Oc2ccccc2)c1,fenoprofen,Fenoprofen calcium salt dihydrate,,MODERATE,LOW,3.87,-3.48,1
,CCCN1CCC=C(c2cc(-c3ccc(C)cc3)no2)C1,,CCCN1CCC=C(c2cc(-c3ccc(C)cc3)no2)C1,,PD 144418 oxalate,,LOW,INACTIVE,4.31,-3.67,0
1450.0,CNC(=O)c1c(I)c(NC(=O)CCCCC(=O)Nc2c(I)c(C(=O)O)c(I)c(C(=O)NC)c2I)c(I)c(C(=O)O)c1I,,CNC(=O)c1c(I)c(NC(=O)CCCCC(=O)Nc2c(I)c(C(=O)O)c(I)c(C(=O)NC)c2I)c(I)c(C(=O)O)c1I,iocarmic acid,Iocarmic acid,,LOW,INACTIVE,2.2,-5.14,0
2531.0,O=C1OC(c2ccc(O)c(S(=O)(=O)O)c2)(c2ccc(O)c(S(=O)(=O)O)c2)c2c(Br)c(Br)c(Br)c(Br)c21,,O=C1OC(c2ccc(O)c(S(=O)(=O)O)c2)(c2ccc(O)c(S(=O)(=O)O)c2)c2c(Br)c(Br)c(Br)c(Br)c21,sulfobromophthalein,Sulfobromophthalein,,HIGH,HIGH,1.03,-5.01,1
4236.0,CCCCC(CC)COC(=O)C=Cc1ccc(OC)cc1,,CCCCC(CC)COC(=O)C=Cc1ccc(OC)cc1,octinoxate,Octinoxate,,HIGH,HIGH,5.62,-5.81,1
611.0,Oc1c(Cl)cc(Cl)c2cccnc12,,Oc1c(Cl)cc(Cl)c2cccnc12,chloroxine,Chloroxine,,HIGH,HIGH,3.44,-3.19,1
,CC12CCC3C4CCC(=O)C=C4CCC3C1CCC2OC(=O)CCc1ccco1,,C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCc1ccco1,,Nandrolone furylpropionate,,MODERATE,HIGH,4.03,-4.65,1
568.0,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,celecoxib,Celecoxib,NCGC00091455-13,MODERATE,HIGH,3.99,-4.88,1
3070.0,CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC,,CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC,articaine,Articaine hydrochloride,,LOW,INACTIVE,1.92,-4.0,0
370.0,c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1,,c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1,bifonazole,Bifonazole,,HIGH,HIGH,5.29,-5.1,1
218.0,COc1ccc(-c2cc(=S)ss2)cc1,,COc1ccc(-c2cc(=S)ss2)cc1,anethole trithione,Anethole trithione,,HIGH,HIGH,3.59,-4.44,1
2678.0,C[N+]12CCCCC1CCC(=C(c1cccs1)c1cccs1)C2,,C[N@+]12CCCC[C@@H]1CCC(=C(c1cccs1)c1cccs1)C2,tiquizium,Tiquizium bromide,,LOW,INACTIVE,1.17,-5.07,0
,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,,Saracatinib,,MODERATE,HIGH,3.56,-3.76,1
2410.0,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=NOCOCCOC)C(C)C(O)C1(C)O,,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O,roxithromycin,Roxithromycin,,LOW,INACTIVE,2.94,-3.65,0
3174.0,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O,,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,eicosapentaenoic acid,Eicosapentaenoic Acid,,LOW,INACTIVE,6.53,-6.02,0
,CN1CCc2c(c3ccccc3n2Cc2ccc(C(=O)NO)cc2)C1,,CN1CCc2c(c3ccccc3n2Cc2ccc(C(=O)NO)cc2)C1,,Tubastatin A,,LOW,INACTIVE,2.76,-3.87,0
1962.0,C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21C,,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C,norethisterone,Norethindrone,,LOW,INACTIVE,2.72,-4.65,0
,COC(=O)C12CCC(C)(C)CC1C1C(=O)C=C3C4(C)C=C(C#N)C(=O)C(C)(C)C4CCC3(C)C1(C)CC2,,COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@](C)(CC[C@H]4C(C)(C)C(=O)C(C#N)=C[C@]34C)[C@]1(C)CC2,,Bardoxolone methyl,NCGC00186460-03,HIGH,HIGH,5.3,-5.23,1
176.0,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,amiodarone,Amiodarone hydrochloride,NCGC00015096-27,HIGH,HIGH,6.5,-5.13,1
,CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(S(=O)Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1,,CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S@@](=O)Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1,,Cenicriviroc Mesylate,,HIGH,HIGH,6.26,-5.95,1
,[H]C([H])([H])C(O)(C(C)C=CC(C)C1CCC2C(=CC=C3CC(O)CC(O)C3)CCCC21C)C([H])([H])[H],,[2H]C([2H])([2H])C(O)([C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C)C([2H])([2H])[2H],,Paricalcitol-D6 (ABT-358),NCGC00379044-02,MODERATE,HIGH,5.27,-4.82,1
720.0,Cc1onc(-c2ccccc2Cl)c1C(=O)NC1C(=O)N2C1SC(C)(C)C2C(=O)O,,Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,cloxacillin,Cloxacillin sodium,,LOW,INACTIVE,2.61,-3.91,0
2621.0,c1ccc2[nH]c(-c3cscn3)nc2c1,,c1ccc2[nH]c(-c3cscn3)nc2c1,thiabendazole,Thiabendazole,NCGC00016410-25,LOW,INACTIVE,2.47,-3.16,0
,CCOCCOC(=O)C=Cc1ccc(OC)cc1,,CCOCCOC(=O)/C=C/c1ccc(OC)cc1,,Cinoxate,,LOW,INACTIVE,2.81,-3.75,0
846.0,NC(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,,N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,dextrothyroxine,L-Thyroxine,NCGC00164336-05,HIGH,HIGH,1.37,-4.94,1
983.0,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,econazole,Econazole nitrate,NCGC00018258-12,HIGH,HIGH,5.23,-5.41,1
4300.0,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2C(CO)C(C)C,,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C,elvitegravir,Elvitegravir,NCGC00346565-07,HIGH,HIGH,3.66,-4.85,1
4829.0,CCOc1cc(C(CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,apremilast,Apremilast (CC-10004),,MODERATE,LOW,1.86,-4.13,1
2999.0,CN1CCCN=C1C=Cc1cccs1,,CN1CCCN=C1/C=C/c1cccs1,pyrantel,Pyrantel tartrate,NCGC00174007-13,LOW,INACTIVE,2.67,-3.24,0
4536.0,COC(=O)Nc1nc2cc(Sc3ccccc3)ccc2[nH]1,,COC(=O)Nc1nc2cc(Sc3ccccc3)ccc2[nH]1,fenbendazole,Fenbendazole,NCGC00016855-19,HIGH,HIGH,3.32,-4.69,1
,CS(=O)(=O)c1cc(-c2ccccc2)cc(S(=O)(=O)c2ccc(CN)s2)c1,,CS(=O)(=O)c1cc(-c2ccccc2)cc(S(=O)(=O)c2ccc(CN)s2)c1,,CCT365623,,LOW,INACTIVE,1.83,-4.49,0
220.0,CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1,,CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1,anileridine,Anileridine,,MODERATE,LOW,4.05,-4.46,1
,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,,Dapivirine?TMC-120,,MODERATE,HIGH,4.11,-4.29,1
4270.0,CCCCC(CC)COC(=O)c1ccc(N(C)C)cc1,,CCCCC(CC)COC(=O)c1ccc(N(C)C)cc1,Padimate O,2-Ethylhexyl 4-(dimethylamino)benzoate,,HIGH,LOW,4.99,-3.89,1
,CC(=NNC(=O)C(NC(=O)c1ccccc1)c1n[nH]c(=O)c2ccccc12)c1cccc(Br)c1,,C/C(=N\NC(=O)C(NC(=O)c1ccccc1)c1n[nH]c(=O)c2ccccc12)c1cccc(Br)c1,,AC-55541,,HIGH,HIGH,2.92,-5.04,1
,Nc1c(CC(=O)[O-])cccc1C(=O)c1ccccc1,,Nc1c(CC(=O)[O-])cccc1C(=O)c1ccccc1,,Amfenac Sodium,,LOW,INACTIVE,2.39,-3.85,0
,O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12,,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,,H-89,,MODERATE,HIGH,2.68,-5.58,1
1937.0,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,nimodipine,Nimodipine,,MODERATE,MODERATE,3.08,-4.56,1
1662.0,CC(=O)C1CCC2C3CC(C)C4=CC(=O)CCC4(C)C3C(O)CC12C,,CC(=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,medrysone,Medrysone,,LOW,INACTIVE,3.08,-4.02,0
,Cc1ccc(Nc2cc(-c3cccc(N4C(=O)c5ccccc5C4=O)c3)ncn2)cc1NS(C)(=O)=O,,Cc1ccc(Nc2cc(-c3cccc(N4C(=O)c5ccccc5C4=O)c3)ncn2)cc1NS(C)(=O)=O,,CDK9 Inhibitor,NCGC00346946-02,HIGH,HIGH,3.74,-4.98,1
1999.0,Cc1ccccc1C(OCCN(C)C)c1ccccc1,,Cc1ccccc1C(OCCN(C)C)c1ccccc1,orphenadrine,Orphenadrine dihydrogen citrate,,LOW,INACTIVE,3.55,-3.95,0
5062.0,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,osimertinib,Osimertinib mesylate,NCGC00378622-10,HIGH,HIGH,4.45,-4.35,1
5046.0,O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)(C2CCCCN2)C1,,O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1,cobimetinib,Cobimetinib,NCGC00346455-02,MODERATE,HIGH,3.33,-4.1,1
242.0,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,aripiprazole,Aripiprazole,NCGC00159510-16,HIGH,LOW,5.21,-4.76,1
,Cc1ccc(C=Nn2c(-c3ccccc3)csc2=S)cc1,,Cc1ccc(/C=N/n2c(-c3ccccc3)csc2=S)cc1,,Fezatione,,HIGH,HIGH,4.71,-5.61,1
403.0,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,bromocriptine,BROMOCRIPTINE,,HIGH,HIGH,3.19,-3.9,1
143.0,CC1CN(CC(Cc2ccccc2)C(=O)NCC(=O)O)CCC1(C)c1cccc(O)c1,,C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c1cccc(O)c1,alvimopan,Alvimopan,NCGC00378640-02,LOW,INACTIVE,3.28,-4.71,0
2597.0,CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,,CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12,terbinafine,Terbinafine,,MODERATE,LOW,5.51,-5.6,1
673.0,CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1,,CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1,clenbuterol,Clenbuterol,,LOW,INACTIVE,2.96,-3.4,0
2570.0,CCCCOC(=O)C(=O)Nc1cccc(-c2nnn[nH]2)c1,,CCCCOC(=O)C(=O)Nc1cccc(-c2nnn[nH]2)c1,tazanolast,Tazanolast,,LOW,INACTIVE,1.78,-3.7,0
1650.0,Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl,,Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl,meclofenamic acid,Meclofenamate sodium,,MODERATE,HIGH,5.08,-4.91,1
,CCC(CC)COC(=O)C(C)NP(=O)(OCC1OC(C#N)(c2ccc3c(N)ncnn23)C(O)C1O)Oc1ccccc1,,CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](O)[C@@H]1O)Oc1ccccc1,,Remdesivir,,MODERATE,HIGH,2.2,-3.25,1
,Cc1cn2nc(C3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)cc2nc1N1CCC(N)C1,,Cc1cn2nc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)cc2nc1N1CC[C@H](N)C1,,Presatovir,,LOW,INACTIVE,3.12,-4.11,0
,Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21,,Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21,,Enzastaurin,NCGC00238452-05,HIGH,HIGH,4.87,-4.76,1
,CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCC3)c1)CC(=O)N2,,CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCC3)c1)CC(=O)N2,,Vesatolimod,NCGC00390283-03,MODERATE,LOW,3.02,-3.81,1
,CCCCCOc1ccc(C2SC(=O)NC2=O)cc1OCC,,CCCCCOc1ccc(C2SC(=O)NC2=O)cc1OCC,,Risarestat,,LOW,MODERATE,3.36,-4.05,0
2333.0,Cc1ncc(CSSCc2cnc(C)c(O)c2CO)c(CO)c1O,,Cc1ncc(CSSCc2cnc(C)c(O)c2CO)c(CO)c1O,pyritinol,Pyrithioxin dihydrochloride,,LOW,INACTIVE,1.57,-3.2,0
,COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCCN1CCCC1,,COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCCN1CCCC1,,UNC-0638,NCGC00189220-12,LOW,MODERATE,6.12,-4.69,0
3369.0,c1ccc2c(CC3=NCCN3)cccc2c1,,c1ccc2c(CC3=NCCN3)cccc2c1,naphazoline,Naphazoline hydrochloride,,LOW,INACTIVE,3.44,-3.74,0
2630.0,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,thiethylperazine,Thiethylperazine dimalate|Thiethylperazine Malate,,HIGH,HIGH,5.12,-4.91,1
1387.0,CCN(CC)CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,,CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,hydrocortamate,Hydrocortamate,,LOW,INACTIVE,2.82,-3.74,0
,C=C1C(=O)OC2C1CCC(C)=CCCC1(C)OC21,,C=C1C(=O)O[C@H]2[C@H]1CCC(C)=CCC[C@@]1(C)O[C@H]21,,Parthenolide,,LOW,INACTIVE,3.03,-3.1,0
3406.0,CCC1CC2C3CCC4=CC(=O)CCC4C3CCC2(C)C1O,,CC[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]2(C)[C@H]1O,oxendolone,Oxendolone,,LOW,INACTIVE,3.37,-4.15,0
182.0,CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1,,CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1,amlexanox,Amlexanox,NCGC00167472-10,MODERATE,HIGH,2.76,-3.31,1
,CCCCCC=CCC=CCCCCCCCC(=O)OCC,,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC,,Ethyl linoleate,,MODERATE,LOW,7.21,-6.87,1
1775.0,CCC(CO)NC(=O)C1C=C2c3cccc4c3c(cn4C)CC2N(C)C1,,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1,methysergide,Methysergide,,LOW,MODERATE,2.2,-3.2,0
4112.0,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,dronedarone,Dronedarone hydrochloride,,HIGH,HIGH,6.46,-5.44,1
13.0,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,,C[C@@H](CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,levdobutamine,Dobutamine,,MODERATE,HIGH,2.97,-4.34,1
1856.0,COc1nc(C)nc(Cl)c1NC1=NCCN1,,COc1nc(C)nc(Cl)c1NC1=NCCN1,moxonidine,Moxonidine hydrochloride hydrate,,LOW,INACTIVE,1.01,-3.33,0
3178.0,CC1(C(=O)O)CCC2(C)CCC3(C)C(=CC(=O)C4C5(C)CCC(O)C(C)(C)C5CCC43C)C2C1,,CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C,enoxolone,ENOXOLONE,NCGC00017244-10,MODERATE,HIGH,5.46,-5.46,1
,CC1(C)CN2C(CSC(=NC3CCCCC3)NC3CCCCC3)=CSC2=N1,,CC1(C)CN2C(CSC(=NC3CCCCC3)NC3CCCCC3)=CSC2=N1,,IT1t dihydrochloride,,LOW,INACTIVE,5.06,-4.62,0
1300.0,CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCC(C)CC3)cc2)C1=O,,CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O,glimepiride,Glimepiride,,MODERATE,HIGH,2.81,-4.12,1
2403.0,CCCN1CCCCC1C(=O)Nc1c(C)cccc1C,,CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C,ropivacaine,Ropivacaine hydrochloride,,LOW,INACTIVE,2.9,-3.04,0
2056.0,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,papaverine,Papaverine hydrochloride,NCGC00015810-26,LOW,HIGH,4.19,-4.42,0
1626.0,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,malathion,Malathion,,LOW,INACTIVE,2.67,-3.3,0
,COP(=S)(OC)SCN1C(=O)c2ccccc2C1=O,,COP(=S)(OC)SCN1C(=O)c2ccccc2C1=O,,Phosmet,,LOW,INACTIVE,2.71,-3.85,0
2198.0,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(OC2CCCCO2)C(C)O1,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O[C@@H]2CCCCO2)[C@H](C)O1,pirarubicin,Pirarubicin,"NCGC00167982-03, NCGC00167982-11",HIGH,HIGH,2.06,-3.32,1
,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=NC(CC(=O)OC(C)(C)C)c1nnc(C)n1-2,,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2,,JQ1,NCGC00250412-08,MODERATE,HIGH,3.58,-4.65,1
486.0,CCN(CC)CCOC(=O)C1(c2ccccc2)CCCC1,,CCN(CC)CCOC(=O)C1(c2ccccc2)CCCC1,caramiphen,Caramiphen edisylate,,LOW,INACTIVE,4.31,-3.82,0
1292.0,C#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C=CC21CC,,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21CC,gestrinone,Gestrinone,,HIGH,HIGH,3.39,-4.5,1
408.0,CN(C)CCC(c1ccc(Br)cc1)c1ccccn1,,CN(C)CCC(c1ccc(Br)cc1)c1ccccn1,brompheniramine,Brompheniramine (maleate),,LOW,INACTIVE,3.62,-4.4,0
,CC(C)(C)OC(=O)Nc1ccc(-c2cc(C(=O)NCCCCCCC(=O)NO)no2)cc1,,CC(C)(C)OC(=O)Nc1ccc(-c2cc(C(=O)NCCCCCCC(=O)NO)no2)cc1,,ISOX,NCGC00250390-10,HIGH,HIGH,3.43,-3.88,1
706.0,CC1CCCC(C)N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,,C[C@H]1CCC[C@@H](C)N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,clopamide,Clopamine,,LOW,INACTIVE,2.17,-3.4,0
2389.0,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,risperidone,Risperidone,,LOW,INACTIVE,3.27,-3.38,0
1513.0,CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,,CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,itraconazole,Itraconazole,NCGC00018268-14,HIGH,HIGH,5.49,-4.86,1
,Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(c(NCc3ccccc3)n1)COCC2,,Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(c(NCc3ccccc3)n1)COCC2,,CB-5083,,MODERATE,LOW,3.32,-4.43,1
1285.0,Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1,,Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1,gemfibrozil,Gemfibrozil,NCGC00016794-14,LOW,INACTIVE,3.59,-3.95,0
,CC(=O)ON=C1C(c2c(O)[nH]c3cc(Br)ccc23)=Nc2ccccc21,,CC(=O)O/N=C1/C(c2c(O)[nH]c3cc(Br)ccc23)=Nc2ccccc21,,6-Bromoindirubin-3'-acetoxime,,HIGH,HIGH,3.99,-4.67,1
2378.0,COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(c(C=NN5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C,,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(C=NN5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,rifapentine,Rifapentine,NCGC00167431-03,HIGH,HIGH,4.7,-4.61,1
1979.0,COC(=O)CCCCC(CCSSC(CCO)=C(C)N(C=O)Cc1cnc(C)nc1N)SC(C)=O,,COC(=O)CCCCC(CCSSC(CCO)=C(C)N(C=O)Cc1cnc(C)nc1N)SC(C)=O,octotiamine,Octotiamine,,LOW,INACTIVE,2.94,-4.55,0
3177.0,C=CCOC(Cn1ccnc1)c1ccc(Cl)cc1Cl,,C=CCOC(Cn1ccnc1)c1ccc(Cl)cc1Cl,enilconazole,Imazalil sulfate,,LOW,INACTIVE,3.71,-3.92,0
109.0,C=CC[N+]12CCC34c5ccccc5N5C=C6C7CC8C9(CC[N+]8(CC=C)CC7=CCO)c7ccccc7N(C=C(C(CC31)C(=CCO)C2)C54)C69,,C=CC[N@@+]12CC[C@@]34c5ccccc5N5C=C6[C@H]7C[C@H]8[C@@]9(CC[N@@+]8(CC=C)C/C7=C/CO)c7ccccc7N(C=C([C@@H](C[C@@H]31)/C(=C\CO)C2)[C@H]54)[C@@H]69,alcuronium,Alcuronium chloride,,LOW,INACTIVE,3.28,-6.48,0
889.0,CCC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12,,CC[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,hydroquinidine,Hydroquinidine HCl,,LOW,INACTIVE,3.36,-3.02,0
1477.0,CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1,,CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1,ipriflavone,Ipriflavone,NCGC00018139-05,LOW,INACTIVE,4.39,-4.8,0
1060.0,CCC(=O)Oc1ccc2c(c1)CCC1C2CCC2(C)C(OC(=O)CC)CCC12,,CCC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](OC(=O)CC)CC[C@@H]12,estradiol dipropionate,"17-BETA-ESTRADIOL 3,17-DIPROPIONATE",,LOW,INACTIVE,5.49,-6.36,0
732.0,Cc1nc2c([nH]1)-c1ccccc1N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC2,,Cc1nc2c([nH]1)-c1ccccc1N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC2,conivaptan,Conivaptan hydrochloride,NCGC00345881-05,HIGH,HIGH,5.22,-5.45,1
188.0,CCC(C)(C)c1ccc(CC(C)CN2CC(C)OC(C)C2)cc1,,CCC(C)(C)c1ccc(CC(C)CN2C[C@H](C)O[C@H](C)C2)cc1,amorolfine,Amorolfine hydrochloride,,LOW,INACTIVE,5.44,-5.61,0
3153.0,CCCCc1cc2ccccc2c(OCCN(C)C)n1,,CCCCc1cc2ccccc2c(OCCN(C)C)n1,quinisocaine,Dimethisoquin hydrochloride,,LOW,INACTIVE,3.9,-3.61,0
,CN(C)Cc1ccc(S(=O)(=O)n2ccc(C=CC(=O)NO)c2)cc1,,CN(C)Cc1ccc(S(=O)(=O)n2ccc(/C=C/C(=O)NO)c2)cc1,,Resminostat,,LOW,INACTIVE,1.1,-3.29,0
421.0,CC(C)=CC(C)=NN=c1[nH]ncc2ccccc12,,CC(C)=CC(C)=NN=c1[nH]ncc2ccccc12,budralazine,Budralazine,,MODERATE,MODERATE,2.52,-3.68,1
489.0,NC(=O)N1c2ccccc2C=Cc2ccccc21,,NC(=O)N1c2ccccc2C=Cc2ccccc21,carbamazepine,Carbamazepine,,LOW,INACTIVE,2.1,-3.19,0
,CC(CCC(=O)[O-])C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C,,C[C@H](CCC(=O)[O-])[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@@]21C,,Sodium deoxycholate monohydrate,,HIGH,HIGH,3.3,-4.41,1
2838.0,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)C=CC(C)C(C)C,,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C,ergocalciferol,ERGOCALCIFEROL,,HIGH,HIGH,7.59,-5.96,1
,CC(=O)OC(C)(C)CCC(=O)C(C)(O)C1C(O)CC2(C)C3CC=C4C(CC(O)C(O)C4(C)C)C3(C)C(=O)CC12C,,CC(=O)OC(C)(C)CCC(=O)[C@](C)(O)C1[C@H](O)C[C@@]2(C)C3CC=C4C(C[C@H](O)[C@@H](O)C4(C)C)[C@]3(C)C(=O)C[C@]12C,,,NCGC00385384-01,MODERATE,HIGH,3.42,-4.69,1
1612.0,CCC(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,lovastatin,Lovastatin,NCGC00023509-18,MODERATE,LOW,4.11,-4.25,1
,CCCCCCCCCCCCCCCCC(C(=O)O)C(O)(CC(=O)O)C(=O)O,,CCCCCCCCCCCCCCCCC(C(=O)O)C(O)(CC(=O)O)C(=O)O,,Agaric acid,,HIGH,HIGH,3.92,-5.22,1
2214.0,O=C(O)CC(O)CC(O)C=Cc1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1,,O=C(O)C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1,pitavastatin,Pitavastatin Calcium|Pitavastatin calcium,,MODERATE,HIGH,3.75,-5.04,1
3617.0,Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1,,Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1,tolnaftate,Tolnaftate,NCGC00016610-12,LOW,INACTIVE,4.86,-5.75,0
633.0,CC(C)C(=O)OCC(=O)C12OC(C3CCCCC3)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,,CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C,ciclesonide,Ciclesonide,NCGC00167972-02,HIGH,HIGH,4.08,-5.54,1
1677.0,CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1,,CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1,melperone,Methylperone,,LOW,INACTIVE,3.89,-3.73,0
,Cc1cc(O)c(C(C)C)cc1Cl,,Cc1cc(O)c(C(C)C)cc1Cl,,6-Chlorothymol,,LOW,INACTIVE,3.75,-3.17,0
1389.0,CCC(=O)OC1(C(=O)COC(C)=O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,,CCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,hydrocortisone aceponate,HYDROCORTISONE ACEPONATE,,LOW,MODERATE,3.26,-4.94,0
4223.0,N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1,,N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1,vilazodone,Vilazodone Hydrochloride,,HIGH,HIGH,4.23,-3.56,1
,CCC(CN)CC(C)CNCC(O)CNCC(CC)CC(CC)CN,,CCC(CN)CC(C)CNCC(O)CNCC(CC)CC(CC)CN,,Sevelamer Hydrochloride (Technical Grade),,LOW,INACTIVE,2.36,-4.89,0
47.0,COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,,COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,acemetacin,Acemetacin,,MODERATE,HIGH,4.06,-5.26,1
40.0,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,acebutolol,Acebutolol hydrochloride,,LOW,INACTIVE,1.43,-3.29,0
588.0,O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1,,O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1,chlorambucil,Chlorambucil,NCGC00015199-24,LOW,MODERATE,3.8,-3.6,0
,CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21,,CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21,,INK-128,,LOW,INACTIVE,1.97,-3.13,0
342.0,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,bepridil,Bepridil,NCGC00015155-14,LOW,MODERATE,5.33,-4.75,0
1666.0,CN(CC1(C)CCCO1)S(=O)(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,,CN(CC1(C)CCCO1)S(=O)(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,mefruside,Mefruside,,LOW,INACTIVE,1.32,-3.24,0
,C=CC=CCC1=C(C)C(OC(=O)C2C(C=C(C)C(=O)OC)C2(C)C)CC1=O,,C=C/C=C\CC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](/C=C(\C)C(=O)OC)C2(C)C)CC1=O,,PYRETHRIN II,,MODERATE,LOW,4.25,-4.81,1
622.0,CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1,,CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1,chlorpropamide,Chlorpropamide,,LOW,INACTIVE,2.15,-3.24,0
,COc1cccc2c(NCc3ccccc3)nc(-n3c(N)nc4ccccc43)nc12,,COc1cccc2c(NCc3ccccc3)nc(-n3c(N)nc4ccccc43)nc12,,KUC107871N,NCGC00347064-04,HIGH,HIGH,4.34,-4.56,1
692.0,CC(C)N=c1cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1,,CC(C)/N=c1\cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1,clofazimine,Clofazimine,,HIGH,HIGH,7.4,-5.5,1
2130.0,O=C1c2ccccc2C(=O)C1c1ccccc1,,O=C1c2ccccc2C(=O)C1c1ccccc1,phenindione,Phenindione,,LOW,MODERATE,3.1,-3.98,0
,CC1(C)CCC2(C(=O)O)CCC3(C)C(=CCC4C5(C)CCC(O)C(C)(C)C5CCC43C)C2C1,,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CCC4[C@@]5(C)CC[C@@H](O)C(C)(C)C5CC[C@]43C)C2C1,,OLEANOIC ACID,,LOW,INACTIVE,7.08,-5.76,0
2712.0,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21,trandolapril,TRANDOLAPRIL,,LOW,INACTIVE,1.28,-4.32,0
,Cc1cc(O)c2c(O)c3c(O)cccc3cc2c1,,Cc1cc(O)c2c(O)c3c(O)cccc3cc2c1,,Chrysarobin,,HIGH,HIGH,2.75,-3.59,1
3257.0,CCOC(=O)c1ccc(OC(=O)CCCCCNC(=N)N)cc1,,CCOC(=O)c1ccc(OC(=O)CCCCCNC(=N)N)cc1,gabexate,Gabexate mesilate,NCGC00025297-06,LOW,INACTIVE,1.84,-3.48,0
2805.0,CCCCC(=O)OCC(=O)C1(O)Cc2c(O)c3c(c(O)c2C(OC2CC(NC(=O)C(F)(F)F)C(O)C(C)O2)C1)C(=O)c1c(OC)cccc1C3=O,,CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O,valrubicin,Valrubicin,NCGC00390545-02,HIGH,HIGH,2.67,-4.35,1
,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2C=NOC(C)(C)C,,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2/C=N/OC(C)(C)C,,Gimatecan,,MODERATE,HIGH,2.91,-4.02,1
,O=C(NO)c1cccc(C(=O)NCCc2ccccc2)c1,,O=C(NO)c1cccc(C(=O)NCCc2ccccc2)c1,,BRD73954,,MODERATE,LOW,1.42,-4.22,1
2809.0,CCCc1nc(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)nn12,,CCCc1nc(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)nn12,vardenafil,Vardenafil,NCGC00167533-04,HIGH,HIGH,2.12,-3.18,1
6.0,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1c1cccc([N+](=O)[O-])c1,(S)-nitrendipine,Nitrendipine,,MODERATE,HIGH,2.69,-4.41,1
,Cc1noc(C)c1-c1ccc2nc(-c3cnn(CC(C)(C)O)c3)nc(N3CCOCC3c3ccccc3)c2c1,,Cc1noc(C)c1-c1ccc2nc(-c3cnn(CC(C)(C)O)c3)nc(N3CCOC[C@@H]3c3ccccc3)c2c1,,,NCGC00483210-07,MODERATE,HIGH,4.8,-3.84,1
2459.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,sorafenib,Sorafenib,NCGC00167488-03,MODERATE,HIGH,4.12,-5.44,1
1861.0,CCC(=O)OC1CC(=O)OC(C)CC=CC=CC(O)C(C)CC(CC=O)C(OC2OC(C)C(OC3CC(C)(O)C(OC(=O)CC)C(C)O3)C(N(C)C)C2O)C1OC,,CCC(=O)O[C@H]1[C@H](C)O[C@@H](O[C@@H]2[C@@H](C)O[C@@H](O[C@@H]3[C@@H](OC)[C@H](OC(=O)CC)CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@@H]3CC=O)[C@H](O)[C@H]2N(C)C)C[C@@]1(C)O,mydecamycin,Midecamycin,,LOW,INACTIVE,3.07,-3.94,0
3966.0,O=C(CCOCCOCCOCCOCCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I,,O=C(CCOCCOCCOCCOCCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I,iodoxamic acid,Iodoxamic Acid,,LOW,LOW,4.13,-5.66,0
,COc1cc(C=CC(=O)CC(=O)C=Cc2ccc(O)c(OC)c2)ccc1O,,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,Curcumin,,HIGH,HIGH,3.62,-4.81,1
,O=C(NCCCNc1nc(Nc2ccc(N3CCOCC3)cc2)ncc1C1CC1)C1CCC1,,O=C(NCCCNc1nc(Nc2ccc(N3CCOCC3)cc2)ncc1C1CC1)C1CCC1,,MRT-68601 hydrochloride,,MODERATE,HIGH,4.17,-4.11,1
,Cc1ccc(N=CN(C)C=Nc2ccc(C)cc2C)c(C)c1,,Cc1ccc(N=CN(C)C=Nc2ccc(C)cc2C)c(C)c1,,Amitraz,,LOW,INACTIVE,4.42,-5.66,0
,NS(=O)(=O)OCC1CC(n2ccc3c(NC4CCc5ccccc54)ncnc32)CC1O,,NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O,,MLN-4924,,MODERATE,HIGH,2.18,-3.51,1
4834.0,CCCCCCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,,CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2,eliglustat,Eliglustat (Tartrate),,LOW,LOW,3.44,-3.55,0
928.0,CCN(CC)C(=S)SSC(=S)N(CC)CC,,CCN(CC)C(=S)SSC(=S)N(CC)CC,disulfiram,Disulfiram,NCGC00016000-21,MODERATE,HIGH,3.88,-4.37,1
4715.0,COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,,COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,cabozantinib,Cabozantinib,NCGC00263164-07,MODERATE,HIGH,3.99,-5.42,1
779.0,C#CC1(O)CCC2C3CCC4=Cc5oncc5CC4(C)C3CCC21C,,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C,danazol,Danazol,,LOW,INACTIVE,3.63,-4.28,0
,CCCCCCCCCCCCCC(=O)OC(C)C,,CCCCCCCCCCCCCC(=O)OC(C)C,,Isopropyl tetradecanoic acid,,LOW,INACTIVE,7.02,-6.39,0
4721.0,O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1,,O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1,lomitapide,Lomitapide,,MODERATE,HIGH,7.18,-6.89,1
,COc1ccc(-c2c(Cl)ncn2-c2ccc(S(N)(=O)=O)cc2)cc1F,,COc1ccc(-c2c(Cl)ncn2-c2ccc(S(N)(=O)=O)cc2)cc1F,,Cimicoxib,,MODERATE,HIGH,3.21,-4.33,1
,CCCC(C)NC(=O)c1ccc(Cl)c(Cl)c1,,CCCC(C)NC(=O)c1ccc(Cl)c(Cl)c1,,NSC 405020,,LOW,INACTIVE,4.05,-4.46,0
4814.0,COc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,,COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1,olodaterol,Olodaterol,,LOW,INACTIVE,2.07,-3.74,0
,CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C=C(\C)CC/C=C(\C)CCC=C(C)C,,Squalene,,LOW,INACTIVE,8.62,-5.91,0
2683.0,Clc1ccc2nsnc2c1NC1=NCCN1,,Clc1ccc2nsnc2c1NC1=NCCN1,tizanidine,Tizanidine hydrochloride,NCGC00160529-08,LOW,INACTIVE,1.61,-3.28,0
,CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,,CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,,Tricaprylin,,LOW,INACTIVE,7.41,-6.87,0
4180.0,CCc1c(Cl)c(O)c(Cl)c(O)c1C(=O)OC1C(C)OC(OCC2=CC=CCC(O)C(C)=CC(CC)C(OC3OC(C)(C)C(OC(=O)C(C)C)C(O)C3O)C(C)=CC(C)=CCC(C(C)O)OC2=O)C(OC)C1O,,CCc1c(Cl)c(O)c(Cl)c(O)c1C(=O)O[C@H]1[C@H](O)[C@H](OC)[C@H](OC/C2=C\C=C\C[C@H](O)/C(C)=C/[C@H](CC)[C@@H](O[C@@H]3OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]3O)/C(C)=C/C(C)=C/C[C@@H]([C@@H](C)O)OC2=O)O[C@@H]1C,fidaxomicin,Fidaxomicin,,HIGH,HIGH,5.6,-4.94,1
1077.0,CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC,,CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC,ethaverine,Ethaverine hydrochloride,,MODERATE,HIGH,5.76,-5.65,1
3181.0,CC12CCC3C(CCC4CC5SC5CC43C)C1CCC2O,,C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H]5S[C@@H]5C[C@@]43C)[C@@H]1CC[C@@H]2O,epitiostanol,Epitiostanol,,LOW,INACTIVE,4.38,-5.69,0
4157.0,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1,,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1,lercanidipine,Lercanidipine hydrochloride,,HIGH,HIGH,6.42,-6.61,1
2113.0,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,perphenazine,Perphenazine,,HIGH,HIGH,4.15,-4.23,1
2335.0,Cc1cc(C=Cc2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1,,Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1,pyrvinium,PYRVINIUM PAMOATE|Pyrvinium pamoate,,HIGH,HIGH,2.05,-6.16,1
2637.0,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,thioridazine,Thioridazine,,HIGH,HIGH,5.93,-5.64,1
3031.0,CC(C)(C)CC(C)(C)c1cc(Cc2cc(C(C)(C)CC(C)(C)C)cc(-n3nc4ccccc4n3)c2O)c(O)c(-n2nc3ccccc3n2)c1,,CC(C)(C)CC(C)(C)c1cc(Cc2cc(C(C)(C)CC(C)(C)C)cc(-n3nc4ccccc4n3)c2O)c(O)c(-n2nc3ccccc3n2)c1,bisoctrizole,"2,2'-Methylenebis[6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol]",,LOW,INACTIVE,8.63,-6.15,0
,CC(C)c1cnn2c(NCc3ccccc3-n3cccn3)nc(OC3CCCNC3)nc12,,CC(C)c1cnn2c(NCc3ccccc3-n3cccn3)nc(OC3CCCNC3)nc12,,LDC4297 (LDC044297),,LOW,INACTIVE,3.42,-4.26,0
,CCOC(=O)Cc1ccc(-c2ccccc2)cc1,,CCOC(=O)Cc1ccc(-c2ccccc2)cc1,,Felbinac ethyl,,MODERATE,HIGH,4.3,-4.98,1
,COc1ccc2cc1Oc1ccc(cc1)CC1c3cc(c(OC)cc3CCN1C)Oc1c(O)c(OC)cc3c1C(C2)N(C)CC3,,COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3cc(c(OC)cc3CCN1C)Oc1c(O)c(OC)cc3c1[C@H](C2)N(C)CC3,,Fangchinoline,,HIGH,HIGH,5.65,-4.85,1
2709.0,CN(C)CCOc1ccc(C(=C(CCCl)c2ccccc2)c2ccccc2)cc1,,CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1,toremifene,Toremifene citrate,NCGC00160530-12,HIGH,HIGH,6.28,-6.0,1
456.0,CCCCOc1ccc(C[N+]2(C)C3CCC2CC(OC(=O)C(CO)c2ccccc2)C3)cc1,,CCCCOc1ccc(C[N+]2(C)[C@H]3CC[C@@H]2C[C@@H](OC(=O)[C@H](CO)c2ccccc2)C3)cc1,butropium,Butropium Bromide,,LOW,INACTIVE,3.42,-6.96,0
4175.0,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,linagliptin,Linagliptin,,MODERATE,HIGH,2.62,-3.97,1
2730.0,CCOC1OC(C(COCc2ccccc2)OCc2ccccc2)C(OCc2ccccc2)C1O,,CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O,tribenoside,Tribenoside,,LOW,INACTIVE,4.11,-5.17,0
679.0,CCCCCCCCCCCCCCCC(=O)OC1C(SC)OC(C(NC(=O)C2CC(CCC)CN2C)C(C)Cl)C(O)C1O,,CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](O)[C@@H](O)[C@@H]([C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl)O[C@@H]1SC,clindamycin palmitate,Clindamycin palmitate HCl,NCGC00185773-02,MODERATE,HIGH,7.02,-5.94,1
361.0,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,bexarotene,Bexarotene,NCGC00181016-19,HIGH,HIGH,6.87,-6.37,1
,CC(NC(=O)CCc1nc2ccccc2c(=O)[nH]1)c1ccccc1,,C[C@H](NC(=O)CCc1nc2ccccc2c(=O)[nH]1)c1ccccc1,,ME 0328,,LOW,INACTIVE,2.43,-3.93,0
4113.0,CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2,,CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2,prasugrel,Prasugrel,NCGC00188690-09,MODERATE,LOW,3.67,-5.2,1
,O=S(=O)(Cl)c1ccc(-c2ccccc2)cc1,,O=S(=O)(Cl)c1ccc(-c2ccccc2)cc1,,Biphenyl-4-sulfonyl chloride,,LOW,INACTIVE,3.65,-4.48,0
2657.0,Clc1ccccc1CN1CCc2sccc2C1,,Clc1ccccc1CN1CCc2sccc2C1,ticlopidine,Ticlopidine hydrochloride,,MODERATE,LOW,4.25,-4.09,1
